SARS-CoV-2 mechanisms of action and impact on human organism, risk factors and potential treatments. An exhaustive survey

References

• Abbott TR, Dhamdhere G, Liu Y, Lin X, Goudy L, Zeng L, Chemparathy A, Chmura S, Heaton NS, Debs R, et al. 2020. Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell. 181(4):865–876.e12. https://doi.org/10.1016/j.cell.2020.04.020.
   PubMed Web of Science ®Google Scholar
• Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, Almeida de Jesus AA, Zarember KA, Alehashemi S, Oikonomou V, Desai JV, et al. 2021. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight. 6(1):e144455. https://doi.org/10.1172/jci.insight.144455.
   Web of Science ®Google Scholar
• Acharya D, Liu G, Gack MU. 2020. Dysregulation of type I interferon responses in COVID-19. Nat Rev Immunol. 20:397–398. https://doi.org/10.1038/s41577-020-0346-x.
   PubMed Web of Science ®Google Scholar
• Adam D. 2021. What scientists know about new, fast-spreading coronavirus variants. Nature. https://doi.org/10.1038/d41586-021-01390-4.
   Google Scholar
• Agrawal B. 2019. Heterologous immunity: role in natural and vaccine-induced resistance to infections. Front Immunol. 10:2631. https://doi.org/10.3389/fimmu.2019.02631.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Advani S, Moreira A, Zoretic S, Martinez J, Chorath K, Acosta S, Naqvi R, Burmeister-Morton F, Burmeister F, et al. 2020. Multisystem inflammatory syndrome in children: a systematic review. Clin Med. 26:100527. https://doi.org/10.1016/j.eclinm.2020.100527.
   Google Scholar
• Al-Aly Z, Xie Y, Bowe B. 2021. High-dimensional characterization of post-acute sequalae of COVID-19. Nature. https://doi.org/10.1038/s41586-021-03553-9.
   Google Scholar
• Alberts B. 2020. Molecular biology of the cell. 6th ed. Garland Science: Taylor & Francis Group.
   Google Scholar
• Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. 2015. Molecular biology of the cell. 6th ed. New York: Garland Science.
   Google Scholar
• Alemany A, Baró B, Ouchi D, Rodó P, Ubals M, Corbacho-Monné M, Vergara-Alert J, Rodon J, Segalés J, Esteban C, et al. 2021. Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test. J Infect. https://doi.org/10.1016/j.jinf.2020.12.033.
   Google Scholar
• Al-Mayhani T, Saber S, Stubbs MJ, Losseff NA, Perry RJ, Simister RJ, Gull D, Jäger HR, Scully MA, Werring DJ. 2021. Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopaenia. Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2021-326984.
   Google Scholar
• Antony AR, Haneef Z. 2020. Systematic review of EEG findings in 617 patients diagnosed with COVID-19. Seizure. 83:234–241 https://doi.org/10.1016/j.seizure.2020.10.014.
   PubMed Web of Science ®Google Scholar
• Arts RJW, Carvalho A, La Rocca C, Palma C, Rodrigues F, Silvestre R, Kleinnijenhuis J, Lachmandas E, Gonçalves LG, Belinha A, et al. 2016. Immunometabolic pathways in BCG-induced trained immunity. Cell Rep. 17. https://doi.org/10.1016/j.celrep.2016.11.011.
   Google Scholar
• Arvin AM, Fink K, Schmid MA, Cathcart A, Spreafico R, Havenar-Daughton C, Lanzavecchia A, Corti D, Virgin HW. 2020. A perspective on potential antibody-dependent enhancement of SARS-CoV-2. Nature. 584:353–363. https://doi.org/10.1038/s41586-020-2538-8.
   PubMed Web of Science ®Google Scholar
• Asher A, Tintle NL, Myers M, Lockshon L, Bacareza H, Harris WS. 2021. Blood omega-3 fatty acids and death from COVID-19: a pilot study. Prostaglandins, Leukotrienes Essent Fatty Acids. 166:102250. https://doi.org/10.1016/j.plefa.2021.102250.
   PubMed Web of Science ®Google Scholar
• Askitas N, Tatsiramos K, Verheyden B. 2021. Estimating worldwide effects of non-pharmaceutical interventions on COVID-19 incidence and population mobility patterns using a multiple-event study. Sci Rep. 11:1972. https://doi.org/10.1038/s41598-021-81442-x.
   PubMed Web of Science ®Google Scholar
• Avci AB, Feist E, Burmester GR. 2018. Targeting IL-6 or IL-6 receptor in rheumatoid arthritis: What’s the difference? BioDrugs. 32:531–546. https://doi.org/10.1007/s40259-018-0320-3.
   PubMed Web of Science ®Google Scholar
• Avendano-Sola C, Ramos-Martinez A, Munez-Rubio E, Ruiz-Antorán B, de Molina RM, Torres F, Fernández-Cruz A, Callejas-Díaz A, Calderón J, Payares-Herrera C, et al. 2020. Convalescent plasma for COVID-19: a multicenter, randomized clinical trial. medRxiv. https://doi.org/10.1101/2020.08.26.20182444.
   Google Scholar
• Ayanian S, Reyes J, Lynn L, Teufel K. 2020. The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort. Biomark Med. 14(12): 1091–1097. https://doi.org/10.2217/bmm-2020-0309.
   PubMed Web of Science ®Google Scholar
• Aydillo T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, Khan Z, Obla A, Dutta J, van Bakel H, Aberg J, García-Sastre A, et al. 2020. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N Engl J Med. 383:2586–2588. https://doi.org/10.1056/NEJMc2031670.
   PubMed Web of Science ®Google Scholar
• Badedi M, Makrami A, Alnami A. 2021. Co-morbidity and blood group type risk in coronavirus disease 2019 patients: a case–control study. J Infect Public Health. 14(4):550–554. https://doi.org/10.1016/j.jiph.2020.12.035.
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. 2020. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. https://doi.org/10.1056/NEJMoa2035389.
   Web of Science ®Google Scholar
• Bairi KE, Trapani D, Petrillo A, Le Page C, Zbakh H, Daniele B, Belbaraka R, Curigliano G, Afqir S. 2020. Repurposing anticancer drugs for the management of COVID-19. Eur J Cancer. 141:40–61. https://doi.org/10.1016/j.ejca.2020.09.014.
   Web of Science ®Google Scholar
• Baldassarre A, Paolini A, Bruno SP, Felli C, Tozzi AE, Masotti A. 2020. Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5’UTR of SARS-CoV-2. Epigenomics. 12(15):1349–1361. https://doi.org/10.2217/epi-2020-0162.
   PubMed Web of Science ®Google Scholar
• Baldassarri M, Picchiotti N, Fava F, Fallerini C, Benetti E, Daga S, Valentino F, Doddato G, Furini S, Giliberti A, et al. 2021. Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males. EBioMedicine. 65:103246. https://doi.org/10.1016/j.ebiom.2021.103246.
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Daßler-Plenker J, Guerci P, Huynh C, Knight JS, et al. 2020, June 1. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med. 217(6):e20200652. https://doi.org/10.1084/jem.20200652.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. 2006. How corticosteroids control inflammation: quintiles prize lecture 2005. Br J Pharmacol. 148(3):245–254. https://doi.org/10.1038/sj.bjp.0706736.
   PubMed Web of Science ®Google Scholar
• Barnkob MB, Pottegård A, Støvring H, Haunstrup TM, Homburg K, Larsen R, Hansen MB, Titlestad K, Aagaard B, Møller BK, et al. 2020. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. Blood Adv. 4(20):4990–4993. https://doi.org/10.1182/bloodadvances.2020002657.
   PubMed Web of Science ®Google Scholar
• Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, et al. 2020. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 370(6515):eabd4585. https://doi.org/10.1126/science.abd4585.
   PubMed Web of Science ®Google Scholar
• Bastiaanssen TFS, Cowan CSM, Claesson MJ, Dinan TG, Cryan JF. 2019. Making sense of … the microbiome in psychiatry. Int J Neuropsuchopharmacolog. 22(1):37–52. https://doi.org/10.1093/ijnp/pyy067.
   PubMed Web of Science ®Google Scholar
• Bazykin GA, Stanevich O, Danilenko D, Fadeev A, Komissarova K, Ivanova A, Sergeeva M, Safina K, Nabieva E, Klink G, et al. Emergence of Y453F and Δ69-70HV mutations in a lymphoma patient with long-term COVID-19. Virological. [accessed 2021 Aug 17]. https://virological.org/t/emergence-of-y453f-and-69-70hv-mutations-in-a-lymphoma-patient-with-long-term-covid-19/580.
   Google Scholar
• Bellmunt S, Riera C, Gil D, Rodríguez M, García-Reyes M, Martínez-Carnovale L, Marrero C, Gil M, Ruiz-Rodríguez JC, Ferrer R, et al. 2020. COVID-19 infection in critically Ill patients carries a high risk for venous thromboembolism. Eur J Vasc Endovasc Surg. https://doi.org/10.1016/j.ejvs.2020.12.015.
   Google Scholar
• Berenguer J, Borobia AM, Ryan P, Rodríguez-Baño J, Bellón JM, Jarrín I, Carratalà J, Pachón J, Carcas AJ, Yllescas M, et al. 2021. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score. Thorax. https://doi.org/10.1136/thoraxjnl-2020-216001.
   Google Scholar
• Blaising J, Polyak SJ, Pécheur E-I. 2014. Arbidol as a broad-spectrum antiviral: an update. Antiviral Res. 107:84–94. https://doi.org/10.1016/j.antiviral.2014.04.006.
   PubMed Web of Science ®Google Scholar
• Blanco JIM, Alvarenga Bonilla JA, Homma S, Suzuki K, Fremont-Smith P, de las Heras KVG. 2021. Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – a retrospective observational study in elderly patients. Pulm Pharmacol Ther. 67:101989. https://doi.org/10.1016/j.pupt.2021.101989.
   Web of Science ®Google Scholar
• Blanco-Melo D, Nilsson-Payant BE, Uhl S, Hoagland D, Møller R, Jordan TX, Oishi K, Panis M, Sachs D, Wang TT, et al. 2020. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 181:1036–1045.e9. https://doi.org/10.1016/j.cell.2020.04.026.
   PubMed Web of Science ®Google Scholar
• Blume C, Jackson CL, Spalluto CM, Legebeke J, Nazlamova L, Conforti F, Perotin JM, Frank M, Butler J, Crispin M, et al. 2021. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection. Nat Genet. https://doi.org/10.1038/s41588-020-00759-x.
   Google Scholar
• Boehme M, Guzzetta KE, Bastiaanssen TFS, van de Wouw M, Moloney GM, Gual-Grau A, Spichak S, Olavarría-Ramírez L, Fitzgerald P, Morillas E, et al. 2021. Microbiota from young mice counteracts selective age-associated behavioral deficits. Nat Aging. 1:666–676. https://doi.org/10.1038/s43587-021-00093-9.
   PubMedGoogle Scholar
• Bonaz B, Bazin T, Pellissier S. 2018. The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci. 12:49. https://doi.org/10.3389/fnins.2018.00049.
   PubMed Web of Science ®Google Scholar
• Bourdrel T, Annesi-Maesano I, Alahmad B, Bind M-A, Maesano CN, Bind MA. 2021. The impact of outdoor air pollution on COVID-19: a review of evidence from in vitro, animal, and human studies. Eur Respir Rev. 30:200242. https://doi.org/10.1183/16000617.0242-2020.
   PubMed Web of Science ®Google Scholar
• Branco ACCC, Sato MN, Alberca RW. 2020. The possible dual role of the ACE2 receptor in asthma and coronavirus (SARS-CoV2) infection. Front Cell Infect Microbiol. 10:550571. https://doi.org/10.3389/fcimb.2020.550571.
   Web of Science ®Google Scholar
• Brauner JM, Mindermann S, Sharma M, Johnston D, Salvatier J, Gavenčiak T, Stephenson AB, Leech G, Altman G, Mikulik V, et al. 2021. Inferring the effectiveness of government interventions against COVID-19. Science. https://doi.org/10.1126/science.abd9338.
   Google Scholar
• Breit S, Kupferberg A, Rogler G, Hasler G. 2018. Vagus nerve as modulator of the brain–Gut axis in psychiatric and inflammatory disorders. Front Psychiatry. 9:44. https://doi.org/10.3389/fpsyt.2018.00044.
   PubMed Web of Science ®Google Scholar
• Broad Institute. Drug repurposing hub. [accessed 2021 Aug 17]. https://clue.io/repurposing.
   Google Scholar
• Buckland MS, Galloway JB, Fhogartaigh CN, Meredith L, Provine NM, Bloor S, Ogbe A, Zelek WM, Smielewska A, Yakovleva A, et al. 2020. Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report. Nat Commun. 11:6385. https://doi.org/10.1038/s41467-020-19761-2.
   Web of Science ®Google Scholar
• Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, Bullock TA, McGary HM, Khan JA, Razmpour R, Hale JF, Galie PA, Potula R, et al. 2020. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier. Neurobiol Dis. 146:105131. https://doi.org/10.1016/j.nbd.2020.105131.
   PubMed Web of Science ®Google Scholar
• Calder Philip C. 2015. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851(4):469–484. http://dx.doi.org/10.1016/j.bbalip.2014.08.010.
   PubMed Web of Science ®Google Scholar
• Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. 2020. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 178:104787. https://doi.org/10.1016/j.antiviral.2020.104787.
   PubMed Web of Science ®Google Scholar
• Campisi J, d'Adda di Fagagna F. 2007. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 8:729–740. https://doi.org/10.1038/nrm2233.
   PubMed Web of Science ®Google Scholar
• Canal-Rivero M, Catalán-Barragán R, Rubio-García A, Garrido-Torres N, Crespo-Facorro B, Ruiz-Veguilla M. 2021. Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish population. Schizophr Res. 229:53–54. https://doi.org/10.1016/j.schres.2021.02.002.
   Web of Science ®Google Scholar
• Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, van der Meer F, Kallio K, Kaya T, Anastasina M, et al. 2020, Nov 13. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 370(6518):856–860. https://doi.org/10.1126/science.abd2985. Epub 2020 Oct 20. PMID: 33082293.
   PubMed Web of Science ®Google Scholar
• Cao L, Goreshnik I, Coventry B, Case James B, Miller L, Kozodoy L, Chen RE, Carter L, Walls AC, Park YJ, et al. 2020, Oct 23. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science. 370(6515):426–431. https://doi.org/10.1126/science.abd9909. Epub 2020 Sep 9. PMID: 32907861.
   PubMed Web of Science ®Google Scholar
• Carrasco-Sánchez FJ, López-Carmona MD, Martínez-Marcos FJ, Pérez-Belmonte LM, Hidalgo-Jiménez A, Buonaiuto V, Suárez Fernández C, Freire Castro SJ, Luordo D, Pesqueira Fontan PM, et al. 2021. Admission hyperglycemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 registry. Ann Med. 53(1):103–116. https://doi.org/10.1080/07853890.2020.1836566.
   PubMed Web of Science ®Google Scholar
• Çayan S, Uğuz M, Saylam B, Akbay E. 2020. Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 (COVID-19) in SARS-CoV-2 infected male patients: a cohort study. Aging Male. https://doi.org/10.1080/13685538.2020.1807930.
   Google Scholar
• CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment (SAC-COVID). [accessed 2021 Aug 17]. https://clinicaltrials.gov/ct2/show/NCT04317040.
   Google Scholar
• Cecchetti G, Vabanesi M, Chieffo R, Fanelli G, Minicucci F, Agosta F, Tresoldi M, Zangrillo A, Filippi M. 2020. Cerebral involvement in COVID-19 is associated with metabolic and coagulation derangements: an EEG study. J Neurol. 267:3130–3134. https://doi.org/10.1007/s00415-020-09958-2.
   Web of Science ®Google Scholar
• Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. 2021. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2:e13–e22. https://doi.org/10.1016/S2666-5247(20)30172-5.
   PubMedGoogle Scholar
• Chaccour C, Casellas A, Matteo AB-D, Pineda I, Fernandez-Montero A, Ruiz-Castillo P, Richardson MA, Rodríguez-Mateos M, Jordán-Iborra C, Brew J, et al. 2021. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trial. EClinicalMedicine. 32:100720. https://doi.org/10.1016/j.eclinm.2020.100720.
   PubMedGoogle Scholar
• Challen R, Brooks-Pollock E, Read J M, Dyson L, Tsaneva-Atanasova K, Danon L. 2021. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. Br Med J. 372:n579. https://doi.org/10.1136/bmj.n579.
   PubMed Web of Science ®Google Scholar
• Charoenngam N, Holick MF. 2020. Immunologic effects of vitamin D on human health and disease. Nutrients. 12:2097. https://doi.org/10.3390/nu12072097.
   PubMed Web of Science ®Google Scholar
• Chen M, Shen W, Rowan NR, Kulaga H, Hillel A, Ramanathan M Jr, Lane AP. 2020a, Sep 24. Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication. Eur Respir J. 56(3):2001948. https://doi.org/10.1183/13993003.01948-2020.
   PubMed Web of Science ®Google Scholar
• Chen W, Feng P, Liu K, Wu M, Lin H. 2020b. Computational Identification of Small Interfering RNA Targets in SARS-CoV-2. Virologica Sinica. 35(3):359–361. http://dx.doi.org/10.1007/s12250-020-00221-6.
   PubMed Web of Science ®Google Scholar
• Chen X, Li R, Pan Z, Qian C, Yang Y, You R, Zhao J, Liu P, Gao L, Li Z, et al. 2020c. Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor. Cellular & Molecular Immunology. 17(6):647–649. http://dx.doi.org/10.1038/s41423-020-0426-7.
   PubMed Web of Science ®Google Scholar
• Chia PY, Xiang Ong SW, Chiew CJ, Ang LW, Chavatte JM, Mak TM, Cui L, Kalimuddin S, Chia WN, Tan CW, et al. 2021. Virological and serological kinetics of SARS-CoV-2 delta variant vaccine-breakthrough infections: a multi-center cohort study. Medrxiv. https://doi.org/10.1101/2021.07.28.21261295.
   Google Scholar
• Chiscano-Camón L, Ruiz-Rodriguez J, Ruiz-Sanmartin A, Roca O, Ferrer R. 2020. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome. Crit Care. 24:522. https://doi.org/10.1186/s13054-020-03249-y.
   Web of Science ®Google Scholar
• Coelho AR, Oliveira PJ. 2020. Dihydroorotate dehydrogenase inhibitors in SARS-CoV-2 infection. Eur J Clin Investig. 50:e13366. https://doi.org/10.1111/eci.13366.
   PubMed Web of Science ®Google Scholar
• Cornejo-Pareja I, Vegas-Aguilar IM, García-Almeida JM, Bellido-Guerrero D, Talluri A, Lukaski H, Tinahones FJ. 2021. Phase angle and standardized phase angle from bioelectrical impedance measurements as a prognostic factor for mortality at 90 days in patients with COVID-19: a longitudinal cohort study. Clin Nutr. https://doi.org/10.1016/j.clnu.2021.02.017.
   Google Scholar
• Coronavirus (COVID-19) Update: FDA authorizes first test that detects neutralizing antibodies from recent or prior SARS-CoV-2 infection. November 06, 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-test-detects-neutralizing-antibodies-recent-or.
   Google Scholar
• Coronavirus (COVID-19) Update: FDA Authorizes Drug for Treatment of COVID-19. 2021. [accessed 2021 Aug 17]. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-treatment-covid-19.
   Google Scholar
• Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19. November 21, 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19.
   Google Scholar
• Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19. November 09, 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibody-treatment-covid-19.
   Google Scholar
• Coronavirus is in the air — there’s too much focus on surfaces. Editorial, 02 February 2021. Nature. Available at https://www.nature.com/articles/d41586-021-00277-8.
   Google Scholar
• COVID-19 Biologics Tracker. [accessed 2021 Aug 17]. https://www.antibodysociety.org/covid-19-biologics-tracker/.
   Google Scholar
• COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). [accessed 2021 Aug 17]. https://gisanddata.maps.arcgis.com/apps/opsdashboard/.
   Google Scholar
• COVID-19 Host Genetics Initiative. 2021. Mapping the human genetic architecture of COVID-19. Nature. https://doi.org/10.1038/s41586-021-03767-x.
   Google Scholar
• COVID-19 Long-Acting AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials. 9 October 2020. https://www.astrazeneca.com/media-centre/press-releases/2020/covid-19-long-acting-antibody-laab-combination-azd7442-rapidly-advances-into-phase-iii-clinical-trials.html.
   Google Scholar
• Cox LS, Bellantuono I, Lord JM, Sapey E, Mannick JB, Partridge L, Gordon AL, Steves CJ, Witham MD. 2020. Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults. Lancet Healthy Longevity. 1(2). https://doi.org/10.1016/S2666-7568(20)30011-8.
   Google Scholar
• Crayne CB, Albeituni S, Nichols KE, Cron RQ. 2019. The immunology of macrophage activation syndrome. Front Immunol. 10:119. https://doi.org/10.3389/fimmu.2019.00119.
   PubMed Web of Science ®Google Scholar
• Crespo-Facorro B, Ruiz-Veguilla M, Vázquez-Bourgon J, Sánchez-Hidalgo AC, Garrido-Torres N, Cisneros JM, Prieto C, Sainz J. 2021. Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysis. Front Pharmacol. 12:646701. https://doi.org/10.3389/fphar.2021.646701.
   PubMed Web of Science ®Google Scholar
• Crimi E, Benincasa G, Figueroa-Marrero N, Galdiero M, Napoli C. 2020. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review. Br J Anaesth. 125:1002–1017. https://doi.org/10.1016/j.bja.2020.06.060.
   Web of Science ®Google Scholar
• Curtis N, Sparrow A, Ghebreyesus TA, Netea MG. 2020. Considering BCG vaccination to reduce the impact of COVID-19. Lancet. 395:1545–1546. https://doi.org/10.1016/S0140-6736(20)31025-4.
   PubMed Web of Science ®Google Scholar
• Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, Hernán MA, Lipsitch M, Reis B, Balicer RD. 2021. BNT162b2 mRNA covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 384:1412–1423. https://doi.org/10.1056/NEJMoa2101765.
   PubMed Web of Science ®Google Scholar
• Damette O, Mathonnat C, Goutte S, Troccoli A. 2021. Meteorological factors against COVID-19 and the role of human mobility. PLOS ONE. 16(6):e0252405. https://doi.org/10.1371/journal.pone.0252405.
   Web of Science ®Google Scholar
• Damialis A, Gilles S, Sofiev M, Sofieva V, Kolek F, Bayr D, Plaza MP, Leier-Wirtz V, Kaschuba S, Ziska LH, et al. 2021, March. Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe. Proc Natl Acad Sci USA. 118(12):e2019034118. https://doi.org/10.1073/pnas.2019034118.
   PubMed Web of Science ®Google Scholar
• Dance A. 2015, May 19. Core concept: CRISPR gene editing. Proc Natl Acad Sci U S A. 112(20):6245–6246. https://doi.org/10.1073/pnas.1503840112. PMID: 25991847; PMCID: PMC4443382.
   Web of Science ®Google Scholar
• Daniloski Z, Jordan TX, Wessels H-H, Hoagland DA, Kasela S, Legut M, Maniatis S, Mimitou EP, Lu L, Geller E, et al. 2021. Identification of required host factors for SARS-CoV-2 infection in human cells. Cell. 184(1):92–105.e16. https://doi.org/10.1016/j.cell.2020.10.030.
   PubMed Web of Science ®Google Scholar
• Debisarun PA, Struycken P, Domínguez-Andrés J, Moorlag SJCFM, Taks E, Gössling KL, Ostermann PN, Müller L, Schaal H, Oever JT, et al. 2020. The effect of influenza vaccination on trained immunity: impact on COVID-19. medRxiv. https://doi.org/10.1101/2020.10.14.20212498.
   Google Scholar
• Demers-Mathieu V, Do DM, Mathijssen GB, Sela DA, Seppo A, Järvinen KM, Medo E. 2020. Difference in levels of SARS-CoV-2 S1 and S2 subunits – and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk. J Perinatol. https://doi.org/10.1038/s41372-020-00805-w.
   Google Scholar
• de Moura MC, Davalos V, Planas-Serra L, Alvarez-Errico D, Arribas C, Ruiz M, Aguilera-Albesa S, Troya J, Valencia-Ramos J, Vélez-Santamaria V, et al. 2021. Epigenome-wide association study of COVID-19 severity with respiratory failure. EBioMedicine. 66:103339. https://doi.org/10.1016/j.ebiom.2021.103339.
   PubMed Web of Science ®Google Scholar
• Depfenhart M, de Villiers D, Lemperle G, Meyer M, Di Somma S. 2020. Potential new treatment strategies for COVID-19: Is there a role for bromhexine as add-on therapy? Intern Emerg Med. 15(5):801–812. https://doi.org/10.1007/s11739-020-02383-3.
   Web of Science ®Google Scholar
• de Vries RD, Schmitz KS, Bovier FT, Predella C, Khao J, Noack D, Haagmans BL, Herfst S, Stearns KL, Drew-Bear J, et al. 2021, Feb 17. Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets. Science. eabf4896. https://doi.org/10.1126/science.abf4896. Epub ahead of print. PMID: 33597220.
   Google Scholar
• de Vrieze J. 2020, March 23. Can a century-old TB vaccine steel the immune system against the new coronavirus?. https://www.sciencemag.org/news/2020/03/can-century-old-tb-vaccine-steel-immune-system-against-new-coronavirus.
   Google Scholar
• Di Micco R, Krizhanovsky V, Baker D, d’Adda di Fagagna F. 2021. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol. 22:75–95. https://doi.org/10.1038/s41580-020-00314-w.
   PubMed Web of Science ®Google Scholar
• Ding Y, Zhou J, Wang S, Li W, Mi Y, Gao S, Xu Y, Chen Y, Yan J. 2018. Anti-neuropilin-1 monoclonal antibody suppresses the migration and invasion of human gastric cancer cells via Akt dephosphorylation. Exp Ther Med. 16(2):537–546. https://doi.org/10.3892/etm.2018.6234.
   PubMed Web of Science ®Google Scholar
• Diorio C, McNerney KO, Lambert M, Paessler M, Anderson EM, Henrickson SE, Chase J, Liebling EJ, Burudpakdee C, Lee JH, et al. 2020. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 4(23):6051–6063. https://doi.org/10.1182/bloodadvances.2020003471.
   PubMed Web of Science ®Google Scholar
• Duarte-Neto AN, Caldini EG, Gomes-Gouvêa MS, Kanamura CT, de Almeida Monteiro RA, Ferranti JF, Ventura AMC, Regalio FA, Fiorenzano DM, Gibelli MABC, et al. 2021. An autopsy study of the spectrum of severe COVID-19 in children: from SARS to different phenotypes of MIS-C. EClinicalMedicine. 35. https://doi.org/10.1016/j.eclinm.2021.100850.
   Google Scholar
• Dufloo J, Grzelak L, Staropoli I, Madec Y, Tondeur L, Anna F, Pelleau S, Wiedemann A, Planchais C, Buchrieser J, et al. 2021. Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies. Cell Reports Med. https://doi.org/10.1016/j.xcrm.2021.100275.
   Google Scholar
• Dutta NK, Mazumdar K, Gordy JT, Dutch RE. 2020. The nucleocapsid protein of SARS-CoV-2: a target for vaccine development. J Virol. 94(13):e00647–20. https://doi.org/10.1128/JVI.00647-20.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Threat assessment brief: rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom. 20 Dec 2020. https://www.ecdc.europa.eu/en/publications-data/threat-assessment-brief-rapid-increase-sars-cov-2-variant-united-kingdom.
   Google Scholar
• Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection. [accessed 2021 Aug 17]. https://clinicaltrials.gov/ct2/show/NCT04747574.
   Google Scholar
• Fang L, Karakiulakis G, Roth M. 2020. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 8. https://doi.org/10.1016/S2213-2600(20)30116-8.
   Google Scholar
• Favalli EG, Biggioggero M, Maioli G, Caporali R. 2020. Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis. 20(9):1012–1013. https://doi.org/10.1016/S1473-3099(20)30262-0.
   PubMed Web of Science ®Google Scholar
• Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, Newburger JW, Kleinman LC, Heidemann SM, Martin AA, et al. 2020. Multisystem inflammatory syndrome in U. S. children and adolescents. New England J Med. 383:334–346. https://doi.org/10.1056/NEJMoa2021680.
   PubMed Web of Science ®Google Scholar
• Ferreira C, Viana SD, Reis F. 2020. Gut microbiota dysbiosis–immune hyperresponse–inflammation triad in coronavirus disease 2019 (COVID-19): impact of pharmacological and nutraceutical approaches. Microorganisms. 8:1514. https://doi.org/10.3390/microorganisms8101514.
   Web of Science ®Google Scholar
• Ferreras C, Pascual-Miguel B, Mestre-Durán C, Navarro-Zapata A, Clares-Villa L, Martín-Cortázar C, De Paz R, Marcos A, Vicario JL, Balas A, et al. 2021. SARS-CoV-2 specific memory T lymphocytes from COVID-19 convalescent donors: identification, biobanking and large-scale production for adoptive cell therapy. Front Cell Dev Biol. 9:620730. https://doi.org/10.3389/fcell.2021.620730.
   Web of Science ®Google Scholar
• Finkel Y, Gluck A, Nachshon A, Winkler R, Fisher T, Rozman B, Mizrahi O, Lubelsky Y, Zuckerman B, Slobodin B, et al. 2021. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis. Nature. https://doi.org/10.1038/s41586-021-03610-3.
   Google Scholar
• Fisher WG, Yang PC, Medikonduri RK, Jafri MS. 2006. NFAT and NFκB activation in T lymphocytes: a model of differential activation of gene expression. Ann Biomed Eng. 34(11):1712–1728. https://doi.org/10.1007/s10439-006-9179-4.
   PubMed Web of Science ®Google Scholar
• Flanagan KL, Best E, Crawford NW, Giles M, Koirala A, Macartney K, Russell F, Teh BW, Wen SCH. 2020. Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines. Front Immunol. 11. https://doi.org/10.3389/fimmu.2020.579250.
   Google Scholar
• Foy BH, Carlson JCT, Reinertsen E, Padros I. Valls R, Pallares Lopez R, Palanques-Tost E, Mow C, Westover MB, Aguirre AD, Higgins JM. 2020. Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection. JAMA Network Open. 3(9):e2022058. https://doi.org/10.1001/jamanetworkopen.2020.22058.
   PubMed Web of Science ®Google Scholar
• Frampton D, Rampling T, Cross A, Bailey H, Heaney J, Byott M, Scott R, Sconza R, Price J, Margaritis M, et al. 2021. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(21)00170-5.
   PubMed Web of Science ®Google Scholar
• Frontera JA, Rahimian JO, Yaghi S, Liu M, Lewis A, de Havenon A, Mainali S, Huang J, Scher E, Wisniewski T, et al. 2020, October 26. Treatment with zinc is associated with reduced in-hospital mortality among COVID-19 patients: a multi-center cohort study, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-94509/v1].
   Google Scholar
• Fuschi C, Pu H, Negri M, Colwell R, Chen J. 2021. Wastewater-based epidemiology for managing the COVID-19 pandemic. ACS ES&T Water. https://doi.org/10.1021/acsestwater.1c00050.
   Google Scholar
• Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, et al. 2021. Evolution of antibody immunity to SARS-CoV-2. Nature. 591:639–644. https://doi.org/10.1038/s41586-021-03207-w.
   PubMed Web of Science ®Google Scholar
• Galvez J, Zanni R, Galvez-Llompart M, Benlloch JM. 2021. Macrolides may prevent severe acute respiratory syndrome coronavirus 2 entry into cells: a quantitative structure activity relationship study and Experimental validation. J Chem Inf Model. 61(4):2016–2025. https://doi.org/10.1021/acs.jcim.0c01394.
   Web of Science ®Google Scholar
• Gao W, Chen S, Wang K, Chen R, Guo Q, Lu J, Wu X, He Y, Yan Q, Wang S, et al. 2020. Clinical features and efficacy of antiviral drug, arbidol in 220 nonemergency COVID-19 patients from east-west-lake shelter hospital in Wuhan: a retrospective case series. Virol J. 17:162. https://doi.org/10.1186/s12985-020-01428-5.
   Web of Science ®Google Scholar
• Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, et al. 2020. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 81(6):e4–e6. https://doi.org/10.1016/j.jinf.2020.08.029.
   PubMed Web of Science ®Google Scholar
• Gene cards. Furin gene. [accessed 2021 Aug 17]. https://www.genecards.org/cgi-bin/carddisp.pl?gene=FURIN.
   Google Scholar
• Ghosh S, Firdous SM, Nath A. 2020. siRNA could be a potential therapy for COVID-19. EXCLI J. 19:528–531. Published 2020 Apr 22. https://doi.org/10.17179/excli2020-1328.
   PubMed Web of Science ®Google Scholar
• GISAID. [accessed 2021 Aug 17]. https://www.gisaid.org/.
   Google Scholar
• Golchin A. 2020. Cell-based therapy for severe COVID-19 patients: clinical trials and cost-utility. Stem Cell Reviews Reports. https://doi.org/10.1007/s12015-020-10046-1.
   Google Scholar
• Gold JE, Baumgartl WH, Okyay RA, Licht WE, Fidel PL, Noverr MC, Tilley LP, Hurley DJ, Rada B, Ashford JW, et al. Nov 2020. Analysis of measles-mumps-rubella (MMR) titers of recovered COVID-19 patients. mBio. 11(6):e02628–20. https://doi.org/10.1128/mBio.02628-20.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rubio J, Navarro-Lopez C, Lopez-Najera E, Lopez-Najera A, Jimenez-Diaz L, Navarro-Lopez JD, Najera A. 2020. Cytokine release syndrome (CRS) and nicotine in COVID-19 patients: trying to calm the storm. Front Immunol. 11:1359. https://doi.org/10.3389/fimmu.2020.01359.
   PubMed Web of Science ®Google Scholar
• Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, Arabi YM, Annane D, Beane A, van Bentum-Puijk W, Berry LR, et al. 2021. Interleukin-6 receptor antagonists in critically Ill patients with covid-19 – preliminary report. The REMAP-CAP investigators. medRxiv; https://doi.org/10.1101/2021.01.07.21249390.
   Google Scholar
• Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O’Meara MJ, Rezelj VV, Guo JZ, Swaney DL, et al. 2020. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 583:459–468. https://doi.org/10.1038/s41586-020-2286-9.
   PubMed Web of Science ®Google Scholar
• Gou W, Fu Y, Yue L, Chen GD, Cai X, Shuai M, Xu F, Yi X, Chen H, Zhu Y, et al. 2021. Gut microbiota, inflammation, and molecular signatures of host response to infection. J Genet Genomics. https://doi.org/10.1016/j.jgg.2021.04.002.
   Google Scholar
• Graham MS, Sudre CH, May A, Antonelli M, Murray B, Varsavsky T, Kläser K, Canas LS, Molteni E, Modat M, et al. 2021. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. Lancet Public Health. https://doi.org/10.1016/S2468-2667(21)00055-4.
   Google Scholar
• Greaney AJ, Loes AN, Crawford KHD, Starr TN, Malone KD, Chu HY, Bloom JD. 2021a. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe. 29(3):463–476.e6. https://doi.org/10.1016/j.chom.2021.02.003.
   PubMed Web of Science ®Google Scholar
• Greaney AJ, Starr TN, Gilchuk P, Zost SJ, Binshtein E, Loes AN, Hilton SK, Huddleston J, Eguia R, Crawford KHD, et al. 2021b. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe. 29(1):44–57.e9. https://doi.org/10.1016/j.chom.2020.11.007.
   PubMed Web of Science ®Google Scholar
• Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. 2021. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. https://doi.org/10.1056/NEJMoa2104840.
   Google Scholar
• Gribble J, Stevens LJ, Agostini ML, Anderson-Daniels J, Chappell JD, Lu X, Pruijssers AJ, Routh AL, Denison MR. 2021. The coronavirus proofreading exoribonuclease mediates extensive viral recombination. PLoS Pathog. 17(1): e1009226. https://doi.org/10.1371/journal.ppat.1009226.
   PubMed Web of Science ®Google Scholar
• Griffin DO, Brennan-Rieder D, Ngo B, Kory P, Confalonieri M, Shapiro L, Iglesias J, Dube M, Nanda N, In GK, et al. 2021. The importance of understanding the stages of COVID-19 in treatment and trials. AIDS Rev. https://doi.org/10.24875/AIDSRev.200001261.
   PubMedGoogle Scholar
• Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, Rawlings SA, Sutherland A, Premkumar L, Jadi RS, et al. 2020. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 181:1489–1501.e15. https://doi.org/10.1016/j.cell.2020.05.015.
   PubMed Web of Science ®Google Scholar
• Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, Guo F, Zhang X, Luo R, Huang C, et al. 2020a. Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza. Clinical Infectious Diseases. 71(10):2669–2678. http://dx.doi.org/10.1093/cid/ciaa709.
   PubMed Web of Science ®Google Scholar
• Gu SH, Yu CH, Song Y, Kim NY, Sim E, Choi JY, Song DH, Hur GH, Shin YK, Jeong ST. 2020b. A small interfering RNA lead targeting RNA-dependent RNA-polymerase effectively inhibit the SARS-CoV-2 infection in golden Syrian hamster and rhesus macaque. bioRxiv. https://doi.org/10.1101/2020.07.07.190967.
   Google Scholar
• Guerra-Silveira F, Abad-Franch F, Nishiura H. 2013. Sex bias in infectious disease epidemiology: patterns and processes. PLoS ONE. 8:e62390. https://doi.org/10.1371/journal.pone.0062390.
   PubMed Web of Science ®Google Scholar
• Guimarães PO, Quirk D, Furtado RH, Maia LN, Saraiva JF, Antunes MO, Kalil Filho R, Junior VM, Soeiro AM, Tognon AP, et al. 2021. Tofacitinib in patients hospitalized with covid-19 pneumonia. N Engl J Med. https://doi.org/10.1056/NEJMoa2101643.
   Google Scholar
• Guisado-Vasco P, Valderas-Ortega S, Carralón-González MM, Roda-Santacruz A, González-Cortijo L, Sotres-Fernández G, Martí-Ballesteros EM, Luque-Pinilla JM, Almagro-Casado E, La Coma-Lanuza FJ, et al. 2020. Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: a retrospective observational study (COQUIMA cohort). EClinicalMedicine. 28:100591. https://doi.org/10.1016/j.eclinm.2020.100591.
   PubMedGoogle Scholar
• Gupta R, Hussain A, Misra A. 2020. Diabetes and COVID-19: evidence, current status and unanswered research questions. Eur J Clin Nutr. 74:864–870. https://doi.org/10.1038/s41430-020-0652-1.
   PubMed Web of Science ®Google Scholar
• Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, Brooks N, Smaja M, Mircus G, Pan K, et al. 2021. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. https://doi.org/10.1016/S0140-6736(21)00947-8.
   Google Scholar
• Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, et al. 2020. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 369:718–724. http://doi.org/10.1126/science.abc6027.
   PubMed Web of Science ®Google Scholar
• Hallal PC, Hartwig FP, Horta BL, Silveira MF, Struchiner CJ, Vidaletti LP, Neumann NA, Pellanda LC, Dellagostin OA, Burattini MN, et al. 2020. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys. Lancet Global Health. 8. https://doi.org/10.1016/S2214-109X(20)30387-9.
   Google Scholar
• Hampshire A, Trendera W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, Mazibuko N, Williams SCR, Barnby JM, Hellyer P, et al. 2021. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2021.101044.
   Google Scholar
• Hanke L, Vidakovics Perez L, Sheward DJ, Das H, Schulte T, Moliner-Morro A, Corcoran M, Achour A, Karlsson Hedestam GB, Hällberg BM, et al. 2020. An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction. Nat Commun. 11:4420. https://doi.org/10.1038/s41467-020-18174-5.
   PubMed Web of Science ®Google Scholar
• Haug N, Geyrhofer L, Londei A, Dervic E, Desvars-Larrive A, Loreto V, Pinior B, Thurner S, Klimek P. 2020. Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav. 4:1303–1312. https://doi.org/10.1038/s41562-020-01009-0.
   PubMed Web of Science ®Google Scholar
• Heffler E, Detoraki A, Contoli M, Papi A, Paoletti G, Malipiero G, Brussino L, Crimi C, Morrone D, Padovani M, et al. 2021. COVID-19 in severe asthma network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments. Allergy. https://doi.org/10.1111/all.14532.
   Google Scholar
• Heuberger J, Trimpert J, Vladimirova D, Goosmann C, Lin M, Schmuck R, Mollenkopf HJ, Brinkmann V, Tacke F, Osterrieder N, et al. 2021. Epithelial response to IFN-γ promotes SARS-CoV-2 infection. EMBO Mol Med. 0:e13191. https://doi.org/10.15252/emmm.202013191.
   Google Scholar
• Hie B, Zhong ED, Berger B, Bryson B. 2021, Jan 15. Learning the language of viral evolution and escape. Science. 371(6526):284–288. https://doi.org/10.1126/science.abd7331. PMID: 33446556.
   Web of Science ®Google Scholar
• Hippich M, Holthaus L, Assfalg R, Zapardiel-Gonzalo J, Kapfelsperger H, Heigermoser M, Haupt F, Ewald DA, Welzhofer TC, Marcus BA, et al. 2020. A public health antibody screening indicates a 6-fold higher SARS-CoV-2 exposure rate than reported cases in children. Med. https://doi.org/10.1016/j.medj.2020.10.003.
   Google Scholar
• Hippich M, Sifft P, Zapardiel-Gonzalo J, Böhmer MM, Lampasona V, Bonifacio E, Ziegler AG. 2021. A public health antibody screening indicates a marked increase of SARS-CoV-2 exposure rate in children during the second wave, Med, https://doi.org/10.1016/j.medj.2021.03.019.
   Google Scholar
• Hirano T, Murakami M. 2020. COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity. 52:731–733. https://doi.org/10.1016/j.immuni.2020.04.003.
   PubMed Web of Science ®Google Scholar
• Hoagland DA, Clarke DJB, Møller R, Han Y, Yang L, Wojciechowicz ML, Lachmann A, Oguntuyo KY, Stevens C, Lee B, et al. 2020. Modulating the transcriptional landscape of SARS-CoV-2 as an effective method for developing antiviral compounds. bioRxiv. https://doi.org/10.1101/2020.07.12.199687.
   PubMedGoogle Scholar
• Hodcroft EB, Zuber M, Nadeau S, Vaughan TG, Crawford KHD, Althaus CL, Reichmuth ML, Bowen JE, Walls AC, Corti D, et al. 2020. Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020. SeqCOVID-SPAIN consortium. Tanja Stadler, Richard A Neher MedRxiv. https://doi.org/10.1101/2020.10.25.20219063.
   Google Scholar
• Hodgson J. 2020. The pandemic pipeline. Nat Biotechnol. 38:523–532. https://doi.org/10.1038/d41587-020-00005-z.
   PubMed Web of Science ®Google Scholar
• Holford P, Carr AC, Jovic TH, Ali SR, Whitaker IS, Marik PE, Smith AD. 2020. Vitamin C—an adjunctive therapy for respiratory infection, sepsis and COVID-19. Nutrients. 12:3760. https://doi.org/10.3390/nu12123760.
   Web of Science ®Google Scholar
• Horby P, Lim WS, Emberson J, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, et al. 2021a. RECOVERY collaborative group. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 384:693–704. https://doi.org/10.1056/NEJMoa2021436.
   PubMed Web of Science ®Google Scholar
• Horby PW, Mafham M, Bell JL, Linsell L, Staplin N, Emberson J, Palfreeman A, Raw J, Elmahi E, Prudon B, et al. 2020. Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 396:1345–1352. https://doi.org/10.1016/S0140-6736(20)32013-4.
   PubMed Web of Science ®Google Scholar
• Hu R, Han C, Pei S, Yin M, Chen X. 2020. Procalcitonin levels in COVID-19 patients. Int J Antimicrob Agents. 56. https://doi.org/10.1016/j.ijantimicag.2020.106051.
   Google Scholar
• Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, et al. 2021. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 397:10270. https://doi.org/10.1016/S0140-6736(20)32656-8.
   Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5.
   PubMed Web of Science ®Google Scholar
• Ibarrondo FJ, Fulcher JA, Goodman-Meza D, Elliott J, Hofmann C, Hausner MA, Ferbas KG, Tobin NH, Aldrovand GM, Yang OO. 2020. Rapid decay of anti–SARS-CoV-2 antibodies in persons with mild covid-19. N Engl J Med. 383:1085–1087. https://doi.org/10.1056/NEJMc2025179.
   PubMed Web of Science ®Google Scholar
• Igase M, Kohara K, Nagai T, Miki T, Ferrario CM. 2008. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade. Hypertens Res. 31:553–559. https://doi.org/10.1291/hypres.31.553.
   PubMed Web of Science ®Google Scholar
• IMB. Functional genomics platform. [accessed 2021 Aug 17]. https://s2s-omxware.us-south.containers.appdomain.cloud/home, https://covid19-mol.mybluemix.net/.
   Google Scholar
• Immune Epitope Database (IEDB). [accessed 2021 Aug 17]. http://www.iedb.org/.
   Google Scholar
• Ioannou GN, Locke E, Green P, Berry K, O’Hare AM, Shah JA, Crothers K, Eastment MC, Dominitz JA, Fan VS. 2020. Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection. JAMA Network Open. 3(9):e2022310. https://doi.org/10.1001/jamanetworkopen.2020.22310.
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Medzhitov R. 2015. Control of adaptive immunity by the innate immune system. Nat Immunol. 16:343–353. https://doi.org/10.1038/ni.3123.
   PubMed Web of Science ®Google Scholar
• James MacLachlan N., and Dubovi Edward J. 2017. Chapter 4 – Antiviral immunity and virus vaccines. In: James MacLachlan N., and Dubovi Edward J., editors. Fenner's veterinary virology. Fifth ed. Academic Press; p. 79–104.
   Google Scholar
• Jamshaid H, Zahid F, Din IU, Zeb A, Choi HG, Khan GM, Din F. 2020. Diagnostic and treatment strategies for COVID-19. AAPS PharmSciTech. 21:222. https://doi.org/10.1208/s12249-020-01756-3.
   Web of Science ®Google Scholar
• Janowitz T, Gablenz E, Pattinson D, Wang TC, Conigliaro J, Tracey K, Tuveson D. 2020. Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series. Gut. 69:1592–1597. http://doi.org/10.1136/gutjnl-2020-321852.
   PubMed Web of Science ®Google Scholar
• Jeon SM, Shin EA. 2018. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 50(20). https://doi.org/10.1038/s12276-018-0038-9.
   Google Scholar
• Jeong GU, Song H, Yoon GY, Kim D, Kwon Y-C. 2020. Therapeutic strategies against COVID-19 and structural characterization of SARS-CoV-2: a review. Front Microbiol. 11:1723. https://doi.org/10.3389/fmicb.2020.01723.
   PubMed Web of Science ®Google Scholar
• Jessica W, Alex R, Jonathan D. 2020. Testing for SARS-CoV-2 antibodies. Br Med J. 370:m3325. https://doi.org/10.1136/bmj.m3325.
   Google Scholar
• Johansson MA, Quandelacy TM, Kada S, Prasad PV, Steele M, Brooks JT, Slayton RB, Biggerstaff M, Butler JC. 2021. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Network Open. 4(1):e2035057. https://doi.org/10.1001/jamanetworkopen.2020.35057.
   PubMed Web of Science ®Google Scholar
• Johnson SC, Rabinovitch PS, Kaeberlein M. 2013. mTOR is a key modulator of ageing and age-related disease. Nature. 493(7432):338–345. https://doi.org/10.1038/nature11861.
   PubMed Web of Science ®Google Scholar
• Joung J, Ladha A, Saito M, Kim NG, Woolley AE, Segel M, Barretto RPJ, Ranu A, Macrae RK, Faure G, et al. 2020. Detection of SARS-CoV-2 with SHERLOCK one-pot testing. N Engl J Med. 383:1492–1494. https://doi.org/10.1056/NEJMc2026172.
   PubMed Web of Science ®Google Scholar
• Joyner MJ, Senefeld JW, Mills JR, Johnson PW, Theel ES, Wiggins CC, Bruno KA, Klompas AM, Lesser ER, Kunze KL, et al. 2020. Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience. medRxiv. https://doi.org/10.1101/2020.08.12.20169359.
   Google Scholar
• Kalra P, Dhiman A, Cho WC, Bruno JG, Sharma TK. 2018. Simple methods and rational design for enhancing aptamer sensitivity and specificity. Front Mol Biosci. 5:41. https://doi.org/10.3389/fmolb.2018.00041.
   Web of Science ®Google Scholar
• Kaneko N, Kuo H-H, Boucau J, Farmer JR, Allard-Chamard H, Mahajan VS, Piechocka-Trocha A, Lefteri K, Osborn M, Bals J, et al. 2020. Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell. 183:143–157.e13. https://doi.org/10.1016/j.cell.2020.08.025.
   PubMed Web of Science ®Google Scholar
• Kang Z, Luo S, Gui Y, Zhou H, Zhang Z, Tian C, Zhou Q, Wang Q, Hu Y, Fan H, et al. 2020. Obesity is a potential risk factor contributing to clinical manifestations of COVID-19. Int J Obes. 44:2479–2485. https://doi.org/10.1038/s41366-020-00677-2.
   Web of Science ®Google Scholar
• Karahan S, Katkat F. 2020. Impact of serum 25(OH) vitamin D level on mortality in patients with COVID-19 in Turkey. J Nutr Health Aging. https://doi.org/10.1007/s12603-020-1479-0.
   Web of Science ®Google Scholar
• Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF, Reddy SV. 2020. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLOS ONE. 15(9):e0239252. https://doi.org/10.1371/journal.pone.0239252.
   PubMed Web of Science ®Google Scholar
• Kemp SA, Collier DA, Datir RP, Ferreira IATM, Gayed S, Jahun A, Hosmillo M, Rees-Spear C, Mlcochova P, Lumb IU, et al. 2021. SARS-CoV-2 evolution during treatment of chronic infection. Nature. https://doi.org/10.1038/s41586-021-03291-y.
   Google Scholar
• Khadke S, Ahmed N, Ahmed N, Ratts R, Raju S, Gallogly M, de Lima M, Sohail MR. 2020. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents. Virol J. 17:154. https://doi.org/10.1186/s12985-020-01415-w.
   PubMed Web of Science ®Google Scholar
• Kimura I, Kosugi Y, Wu J, Yamasoba D, Butlertanaka EP, Tanaka YL, Liu Y, Shirakawa K, Kazuma Y, Nomura R, et al. 2021. SARS-CoV-2 lambda variant exhibits higher infectivity and immune resistance. Biorxiv. https://doi.org/10.1101/2021.07.28.454085.
   Google Scholar
• Kiros M, Andualem H, Kiros T, Hailemichael W, Getu S, Geteneh A, Alemu D, Abegaz WE. 2020. COVID-19 pandemic: current knowledge about the role of pets and other animals in disease transmission. Virol J. 17:143. https://doi.org/10.1186/s12985-020-01416-9.
   PubMed Web of Science ®Google Scholar
• Kissler S, Fauver JR, Mack C, Tai CG, Breban MI, Watkins AE, Samant RM, Anderson DJ, Ho DD, Grubaugh ND, et al. 2021. Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2. Preprint. https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37366884.
   Google Scholar
• Klang S, Mann B, Meggido D, Tair L, Naparstek Y. 2021, January 20. Low pH Hypromellose (Taffix™) nasal powder spray reduced SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: An observational prospective open label user survey, PREPRINT (Version 2) available at Research Square. https://doi.org/10.21203/rs.3.rs-100328/v2.
   Google Scholar
• Klein S, Flanagan K. 2016. Sex differences in immune responses. Nat Rev Immunol. 16:626–638. https://doi.org/10.1038/nri.2016.90.
   PubMed Web of Science ®Google Scholar
• Kokic G, Hillen HS, Tegunov D, Dienemann C, Seitz F, Schmitzova J, Farnung L, Siewert A, Höbartner C, Cramer P. 2021. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nat Commun. 12:279. https://doi.org/10.1038/s41467-020-20542-0.
   PubMed Web of Science ®Google Scholar
• Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, et al. 2020. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 182(4):812–827.e19. https://doi.org/10.1016/j.cell.2020.06.043.
   PubMed Web of Science ®Google Scholar
• Kow CS, Capstick T, Hasan SS. 2021. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? Allergy. https://doi.org/10.1111/all.14589.
   Google Scholar
• Kowarz E, Krutzke L, Reis J, Bracharz S, Kochanek S, Marschalek R. 2021, May 26. “Vaccine-Induced Covid-19 Mimicry” Syndrome: Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines. PREPRINT (Version 1) available at Research Square, https://doi.org/10.21203/rs.3.rs-558954/v1.
   Google Scholar
• Krammer F. 2020. SARS-CoV-2 vaccines in development. Nature. 586:516–527. https://doi.org/10.1038/s41586-020-2798-3.
   PubMed Web of Science ®Google Scholar
• Kumar S, Zhi K, Mukherji A, Gerth K. 2020. Repurposing antiviral protease inhibitors using extracellular vesicles for potential Therapy of COVID-19. Viruses. 12(5):486. Published 2020 Apr 26. https://doi.org/10.3390/v12050486.
   PubMed Web of Science ®Google Scholar
• Kuo C-L, Pilling LC, Atkins JL, Masoli JAH, Delgado J, Kuchel GA, Melzer D. 2020, November. APOE e4 genotype predicts severe COVID-19 in the UK biobank community cohort. J Gerontol: Ser A. 75(11):2231–2232. https://doi.org/10.1093/gerona/glaa131.
   PubMed Web of Science ®Google Scholar
• Kwok S, Adam S, Ho JH, Iqbal Z, Turkington P, Razvi S, Le Roux CW, Soran H, Syed AA. 2020. Obesity: a critical risk factor in the COVID-19 pandemic. Clin Obes. 10. https://doi.org/10.1111/cob.12403.
   Google Scholar
• Kwon PS, Oh H, Kwon SJ, Jin W, Zhang F, Fraser K, Hong JJ, Linhardt RJ, Dordick JS. 2020. Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro. Cell Discov. 6:50. https://doi.org/10.1038/s41421-020-00192-8.
   PubMed Web of Science ®Google Scholar
• La Marca A, Capuzzo M, Paglia T, Roli L, Trenti T, Nelson SM. Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays, Reproductive BioMedicine Online 41, 2020, https://doi.org/10.1016/j.rbmo.2020.06.001.
   Google Scholar
• Laxminarayan R, Wahl B, Dudala SR, Gopal K, Mohan BC, Neelima S, Jawahar RKS, Radhakrishnan J, Lewnard JA. 2020, Nov 6. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science. 370(6517):691–697. https://doi.org/10.1126/science.abd7672. Epub 2020 Sep 30. PMID: 33154136.
   PubMed Web of Science ®Google Scholar
• Ledford H. Nature. How does COVID-19 kill? Uncertainty is hampering doctors’ ability to choose treatments. 9 April 2020. https://www.nature.com/articles/d41586-020-01056-7.
   Google Scholar
• Lee C, Choi WJ. 2021. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective. Arch Pharmacal Res. 44. https://doi.org/10.1007/s12272-020-01301-7.
   Google Scholar
• Lee S, Channappanavar R, Kanneganti T-D. 2020. Coronaviruses: innate immunity, inflammasome activation, inflammatory cell death, and cytokines. Trends Immunol. 41. https://doi.org/10.1016/j.it.2020.10.005.
   Google Scholar
• Lehrer S, Rheinstein PH. 2021. ABO blood groups, COVID-19 infection and mortality. Blood Cells, Molecules, Diseases. 89:102571. https://doi.org/10.1016/j.bcmd.2021.102571.
   Web of Science ®Google Scholar
• Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, Zhang Y, Yin Q, Cho Y, Andrade L, et al. 2021. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 128(9):1323–1326. https://doi.org/10.1161/CIRCRESAHA.121.318902.
   PubMed Web of Science ®Google Scholar
• Li F, Li Y-Y, Liu M-J, Fang L-Q, Dean NE, Wong QWK, Yang X-B, Longini I, Halloran ME, Wang H-J, et al. 2021a. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)30981-6.
   Google Scholar
• Li G, De Clercq E. 2020. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discovery. 19:149–150. https://doi.org/10.1038/d41573-020-00016-0.
   PubMed Web of Science ®Google Scholar
• Li H, Zhou Y, Zhang M, Wang H, Zhao Q, Liu J. 2020a. Updated approaches against SARS-CoV-2. Antimicrob Agents Chemother. 64:e00483–20. https://doi.org/10.1128/AAC.00483-20.
   PubMed Web of Science ®Google Scholar
• Li J, Guo M, Tian X, Wang X, Yang X, Wu P, Liu C, Xiao Z, Qu Y, Yin Y, et al. 2021b. Virus-host interactome and proteomic survey reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. Med. 2(1):99–112.E7. https://doi.org/10.1016/j.medj.2020.07.002.
   Web of Science ®Google Scholar
• Li W, Schäfer A, Kulkarni SS, Liu X, Martinez DR, Chen C, Sun Z, Leist SR, Drelich A, Zhang L, et al. 2020b. High potency of a bivalent human VH domain in SARS-CoV-2 animal models. Cell. 183. https://doi.org/10.1016/j.cell.2020.09.007.
   Google Scholar
• Li Y, Campbell H, Kulkarni D, Harpur A, Nundy M, Wang X, Nair H. 2021c. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. The Lancet Infectious Diseases. 21(2):193–202. http://dx.doi.org/10.1016/S1473-3099(20)30785-4.
   PubMed Web of Science ®Google Scholar
• Libster R, Marc GP, Wappner D, Coviello S, Bianchi A, Braem V, Esteban I, Caballero MT, Wood C, Berrueta M, et al. 2021. Early high-titer plasma therapy to prevent severe Covid-19 in older adults. N Engl J Med. https://doi.org/10.1056/NEJMoa2033700.
   Web of Science ®Google Scholar
• Lieberman NAP, Peddu V, Xie H, Shrestha L, Huang ML, Mears MC, Cajimat MN, Bente BA, Shi P-Y, Bovier F, et al. 2020. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age. PLoS Biol. 18(9):e3000849. https://doi.org/10.1371/journal.pbio.3000849.
   PubMed Web of Science ®Google Scholar
• Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting. 2020, September 16. https://investor.lilly.com/news-releases/news-release-details/lilly-announces-proof-concept-data-neutralizing-antibody-ly.
   Google Scholar
• Lim D, Rocchio F, Mapelli L, Moccia F. 2016. From pathology to physiology of calcineurin signalling in astrocytes. Opera Medica et Physiologica. 2(2):122–140. https://doi.org/10.20388/OMP2016.002.0029.
   Google Scholar
• Lindan CE, Mankad K, Ram D, Kociolek LK, Silvera VM, Boddaert N, Stivaros SM, Palasis S, Akhtar S, Alden D, et al. 2020. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health. https://doi.org/10.1016/S2352-4642(20)30362-X.
   Google Scholar
• Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, Koralnik IJ 2020. Frequent neurologic manifestations and encephalopathy-associated morbidity in covid-19 patients. Ann Clin Transl Neurol. 7:2221–2230. https://doi.org/10.1002/acn3.51210.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M. 2020. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med (CCLM). 58(7):1131–1134. https://doi.org/10.1515/cclm-2020-0198.
   Google Scholar
• Liu F, Xu A, Zhang Y, Xuan W, Yan T, Pan K, Yu W, Zhang J 2020. Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression. Int J Infect Dis. 95. https://doi.org/10.1016/j.ijid.2020.03.013.
   Google Scholar
• Liu T, Zhang L, Joo D, Sun S-C, 2017. NF-κB signaling in inflammation. Signal Transduction Targeted Ther. 2:17023. https://doi.org/10.1038/sigtrans.2017.23.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu J, Xia H, Zhang X, Fontes-Garfias CR, Swanson KA, Cai H, Sarkar R, Chen W, Cutler M, et al. 2021a. Neutralizing Activity of BNT162b2-Elicited Serum. New England Journal of Medicine. 384(15):1466–1468. http://dx.doi.org/10.1056/NEJMc2102017.
   PubMed Web of Science ®Google Scholar
• Liu Y, Morgenstern C, Kelly J, Lowe R, Jit M. 2021b. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories. BMC Medicine. 19(1):553. http://dx.doi.org/10.1186/s12916-020-01872-8.
   Web of Science ®Google Scholar
• Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, et al. 2021. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. https://doi.org/10.1016/S0140-6736(21)00234-8.
   Google Scholar
• London researchers to test promising coronavirus treatment. Julia Bakker. 15 June 2020. https://www.bhf.org.uk/what-we-do/news-from-the-bhf/news-archive/2020/june/london-researchers-to-test-promising-coronavirus-treatment.
   Google Scholar
• Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, Hu JL, Xu W, Zhang Y, Lv FJ, et al. 2020. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 26:1200–1204. https://doi.org/10.1038/s41591-020-0965-6.
   PubMed Web of Science ®Google Scholar
• Losina E, Leifer V, Millham L, Panella C, Hyle EP, Mohareb AM, Neilan AM, Ciaranello AL, Kazemian P, Freedberg KA. College campuses and COVID-19 mitigation: clinical and economic value. Ann Intern Med. Epub ahead of print 2020, December 21. https://doi.org/10.7326/M20-6558.
   Google Scholar
• Lu H, Weintz C, Pace J, Indana D, Linka K, Kuhl E. 2021. Are college campuses superspreaders? A data-driven modeling study. Comput Methods Biomech Biomed Engin. https://doi.org/10.1080/10255842.2020.1869221.
   Google Scholar
• Mahdi M, Mótyán JA, Szojka ZI, Golda M, Miczi M, Tőzsér J. 2020. Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease. Virol J. 17:190. https://doi.org/10.1186/s12985-020-01457-0.
   Web of Science ®Google Scholar
• Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I. 2020 Sep. COVID-19 cytokine storm: the anger of inflammation. Cytokine. 133:155151. https://doi.org/10.1016/j.cyto.2020.155151. Epub 2020 May 30. PMID: 32544563; PMCID: PMC7260598.
   PubMed Web of Science ®Google Scholar
• Maltagliati S, Sieber S, Sarrazin P, Cullati S, Chalabaev A, Millet GP, Boisgontier MP, Cheval B. 2021. Muscle strength explains the protective effect of physical activity against COVID-19 hospitalization among adults aged 50 years and older. medRxiv. https://doi.org/10.1101/2021.02.25.21252451.
   Google Scholar
• Manirul Haque SK, Ashwaq O, Sarief A, Azad John Mohamed AK. 2020. A comprehensive review about SARS-CoV-2. Future Virol. 15(9):625–648. https://doi.org/10.2217/fvl-2020-0124.
   Web of Science ®Google Scholar
• Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, Petrey AC, Tolley ND, Guo L, Cody M, et al. 2020. Platelet gene expression and function in patients with COVID-19. Blood. 136(11):1317–1329. https://doi.org/10.1182/blood.2020007214.
   PubMed Web of Science ®Google Scholar
• Mannick JB, Morris M, Hockey HP, Roma G, Beibel M, Kulmatycki K, Watkins M, Shavlakadze T, Zhou W, Quinn D, et al. 2018, July 11. TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med. 10(449):eaaq1564. https://doi.org/10.1126/scitranslmed.aaq1564. PMID: 29997249.
   PubMed Web of Science ®Google Scholar
• Marín-Hernández D, Schwartz RE, Nixon DF. 2021. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy. J Med Virol. 93:64–65. https://doi.org/10.1002/jmv.26120.
   Web of Science ®Google Scholar
• Marouf N, Cai W, Said KN, Daas H, Diab H, Chinta VR, Hssain AA, Nicolau B, Sanz M, Tamimi F. 2021. Association between periodontitis and severity of COVID-19 infection: a case-control study. J Clin Periodontol. Accepted Author Manuscript. https://doi.org/10.1111/jcpe.13435.
   Google Scholar
• Martínez-Fleta P, Alfranca A, González-Álvaro I, Casasnovas JM, Fernández-Soto D, Esteso G, Cáceres-Martell Y, Gardeta S, López-Sanz C, Prat S, et al. 2020, December 1. SARS-CoV-2 cysteine-like protease antibodies can be detected in serum and saliva of COVID-19–seropositive individuals. J Immunol. 205(11):3130–3140. https://doi.org/10.4049/jimmunol.2000842.
   Web of Science ®Google Scholar
• Masana L, Correig E, Rodríguez-Borjabad C, Anoro E, Arroyo JA, Jericó C, Pedragosa A, Miret M, Näf S, Pardo A, et al. 2020. On behalf of the STACOV-XULA research group. Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients, European Heart Journal – Cardiovascular Pharmacotherapy, pvaa128, https://doi.org/10.1093/ehjcvp/pvaa128.
   Google Scholar
• McComb S, Thiriot A, Akache B, Krishnan L, Stark F. 2019. Introduction to the immune system. In: Fulton K., Twine S, editor. Immunoproteomics. Methods in molecular biology, vol 2024. New York, NY: Humana; https://doi.org/10.1007/978-1-4939-9597-4_1.
   Google Scholar
• McDade J. Genome-wide screening using CRISPR. Updated on Aug 20, 2020. https://blog.addgene.org/genome-wide-screening-using-crispr/cas9.
   Google Scholar
• Medeiros D. Mar 4, 2020. Press release: generex signs contract with EpiVax to develop Ii-key peptide vaccines to address the coronavirus pandemic. https://epivax.com/news/press-release-generex-signs-contract-with-epivax-to-develop-ii-key-peptide-vaccines-to-address-the-coronavirus-pandemic.
   Google Scholar
• Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, Laue M, Schneider J, Brünink S, Greuel S, et al. 2020. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. https://doi.org/10.1038/s41593-020-00758-5.
   Google Scholar
• Meister TL, Brüggemann Y, Todt D, Conzelmann C, Müller JA, Groß R, Münch J, Krawczyk A, Steinmann J, Steinmann J, et al. 2020, October 15. Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2. J Infect Dis. 222(8):1289–1292. https://doi.org/10.1093/infdis/jiaa471.
   Web of Science ®Google Scholar
• Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, Frenkel-Morgenstern M. 2020. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J. 287:3693–3702. https://doi.org/10.1111/febs.15495.
   PubMed Web of Science ®Google Scholar
• Messner CB, Demichev V, Wendisch D, Michalick L, White M, Freiwald A, Textoris-Taube K, Vernardis SI, Egger AS, Kreidl M, et al. 2020. Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst. 11:11–24.e4. https://doi.org/10.1016/j.cels.2020.05.012.
   PubMed Web of Science ®Google Scholar
• Milken Institute. COVID-19 treatment and vaccine tracker. Last updated: February 2, 2021. https://covid-19tracker.milkeninstitute.org/.
   Google Scholar
• Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP. 2020, July. The implications of silent transmission for the control of COVID-19 outbreaks. Proc Natl Acad Sci USA. 117(30):17513–17515. https://doi.org/10.1073/pnas.2008373117.
   PubMed Web of Science ®Google Scholar
• Mogul A, Corsi K, McAuliffe L. 2019 Sep. Baricitinib: the second FDA-approved JAK inhibitor for the treatment of rheumatoid arthritis. Ann Pharmacother. 53(9):947–953. https://doi.org/10.1177/1060028019839650. Epub 2019 Mar 24. PMID: 30907116.
   PubMed Web of Science ®Google Scholar
• Monk PD, Marsden RJ, Tear VJ, Brookes J, Batten TN, Mankowski M, Gabbay FJ, Davies DE, Holgate ST, Ho LP, et al. 2020. Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30511-7.
   Google Scholar
• Monoclonal Antibodies Overview. [accessed 2021 Aug 17]. https://www.genscript.com/how-to-make-monoclonal-antibodies.html.
   Google Scholar
• Moorlag SJCFM, Arts RJW, van Crevel R, Netea MG. 2019. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect. 25. https://doi.org/10.1016/j.cmi.2019.04.020.
   Google Scholar
• Moutal A, Martin L, Boinon L, Gomez K, Ran D, Zhou Y, Stratton HJ, Cai S, Luo S, Gonzalez KB, et al. 2021, January. SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia. PAIN. 162(1):243–252. https://doi.org/10.1097/j.pain.0000000000002097.
   PubMed Web of Science ®Google Scholar
• Munnink BB O, Sikkema RS, Nieuwenhuijse DF, Molenaar RJ, Munger E, Molenkamp R, van der Spek A, Tolsma P, Rietveld A, Brouwer M, et al. 2021. Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science. http://doi.org/10.1126/science.abe5901.
   Google Scholar
• Muñoz X, Pilia F, Ojanguren I, Romero-Mesones C, Cruz MJ. 2020. Is asthma a risk factor for COVID-19? Are phenotypes important? ERJ Open Res. https://doi.org/10.1183/23120541.00216-2020.
   Google Scholar
• Muñoz-Basagoiti J, Perez-Zsolt D, León R, Blanc V, Raïch-Regué D, Cano-Sarabia M, Trinité B, Pradenas E, Blanco J, Gispert J, et al. 2021, July. Mouthwashes with CPC reduce the infectivity of SARS-CoV-2 variants in vitro. J Dent Res. https://doi.org/10.1177/00220345211029269.
   Google Scholar
• NCBI Resources. Gene. EEF1A1 eukaryotic translation elongation factor 1 alpha 1. Updated on 2021, Jan 29. https://www.ncbi.nlm.nih.gov/gene/1915.
   Google Scholar
• Neeland MR, Bannister S, Clifford V, Dohle K, Mulholland K, Sutton P, Curtis N, Steer AC, Burgner DP, Crawford NW, et al. 2021. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children. Nat Commun. 12:1084. https://doi.org/10.1038/s41467-021-21414-x.
   PubMed Web of Science ®Google Scholar
• Nelde A, Bilich T, Heitmann JS, Maringer Y, Salih HR, Roerden M, Lübke M, Bauer J, Rieth J, Wacker M, et al. SARS-CoV-2 T-cell epitopes define heterologous and COVID-19-induced T-cell recognition, 2020, June 16. PREPRINT available at Research Square. https://doi.org/10.21203/rs.3.rs-35331/v1.
   Google Scholar
• Nelson CW, Ardern Z, Goldberg TL, Meng C, Kuo CH, Ludwig C, Kolokotronis SO, Wei X. 2020. Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic. eLife. 9:e59633. https://doi.org/10.7554/eLife.59633.
   Web of Science ®Google Scholar
• Nguyen A, David JK, Maden SK, Wood MA, Weeder BR, Nellore A, Thompson RF, Gallagher T. 2020, June. Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. J Virol. 94(13):e00510–20. https://doi.org/10.1128/JVI.00510-20.
   Web of Science ®Google Scholar
• NHS. Men make more coronavirus antibodies than women, making them better plasma donors. 2020, June 23. https://www.nhsbt.nhs.uk/news/men-make-more-coronavirus-antibodies-than-women/.
   Google Scholar
• Nigro P, Pompilio G, Capogrossi M. 2013. Cyclophilin A: a key player for human disease. Cell Death Disease. 4:e888. https://doi.org/10.1038/cddis.2013.410.
   PubMed Web of Science ®Google Scholar
• Nogrady B. 2020. How kids’ immune systems can evade COVID. Nature. 588:382. https://doi.org/10.1038/d41586-020-03496-7.
   Web of Science ®Google Scholar
• Nojomi M, Yassin Z, Keyvani H, Makiani MJ, Roham M, Laali A, Dehghan N, Navaei M, Ranjbar M. 2020. Effect of arbidol (umifenovir) on COVID-19: a randomized controlled trial. BMC Infect Dis. 20:954. https://doi.org/10.1186/s12879-020-05698-w.
   PubMed Web of Science ®Google Scholar
• Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial. 2021, January 28. https://ir.novavax.com/node/15506/pdf.
   Google Scholar
• Nuovo GJ, Magro C, Shaffer T, Awad H, Suster D, Mikhail S, He B, Michaille JJ, Liechty B, Tili E. 2021. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein. Ann Diagn Pathol. 51:151682. https://doi.org/10.1016/j.anndiagpath.2020.151682.
   PubMed Web of Science ®Google Scholar
• O’Donnell VB, Thomas D, Stanton R, Maillard JY, Murphy RC, Jones SA, Humphreys I, Wakelam MJO, Fegan C, Wise MP, et al. 2020. Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection. Function. 1(1):zqaa002. https://doi.org/10.1093/function/zqaa002.
   Google Scholar
• Oldenburg CE, Doan T. 2020. Azithromycin for severe COVID-19. Lancet. 396:936–937. https://doi.org/10.1016/S0140-6736(20)31863-8.
   PubMed Web of Science ®Google Scholar
• Onco’Zine. Plitidepsin – a novel Anti-cancer agent possibly active against COVID19. Peter Hofland. March 16, 2020. https://www.oncozine.com/plitidepsin-a-novel-anti-cancer-agent-possibly-active-against-covid18/.
   Google Scholar
• O’Neill LAJ, Netea MG. 2020. BCG-induced trained immunity: Can it offer protection against COVID-19? Nat Rev Immunol. 20:335–337. https://doi.org/10.1038/s41577-020-0337-y.
   PubMed Web of Science ®Google Scholar
• Oryzon. 2021. Vafidemstat. [accessed 2021 Aug 17]. https://www.oryzon.com/es/programas/vafidemstat.
   Google Scholar
• Osman MM, Lulic D, Glover L, Stahl CE, Lau T, van Loveren H, Borlongan CV. 2011. Cyclosporine-A as a neuroprotective agent against stroke: its translation from laboratory research to clinical application. Neuropeptides. 45:359–368. https://doi.org/10.1016/j.npep.2011.04.002.
   PubMed Web of Science ®Google Scholar
• Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, Walker S, Parkinson N, Fourman MH, Russell CD, et al. 2020. Genetic mechanisms of critical illness in covid-19. Nature. https://doi.org/10.1038/s41586-020-03065-y.
   PubMed Web of Science ®Google Scholar
• Pamukçu B. 2020. Inflammation and thrombosis in patients with COVID-19: a prothrombotic and inflammatory disease caused by SARS coronavirus-2. Anatolian J Cardiol. 24(4):224–234. https://doi.org/10.14744/AnatolJCardiol.2020.56727.
   Web of Science ®Google Scholar
• Patterson BK, Guevara-Coto J, Yogendra R, Francisco EB, Long E, Pise A, Rodrigues H, Parikh P, Mora J, Mora-Rodríguez RA. 2021. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol. 12:700782. https://doi.org/10.3389/fimmu.2021.700782.
   PubMed Web of Science ®Google Scholar
• Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, Rosser EC, Webb K, Deakin CT. 2020. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 11:6317. https://doi.org/10.1038/s41467-020-19741-6.
   PubMed Web of Science ®Google Scholar
• Pérez-Gómez B, Pastor-Barriuso R, Pérez-Olmeda M, Hernán MA, Oteo-Iglesias J, Fernández de Larrea N, Fernández-García A, Martín M, Fernández-Navarro P, Cruz I, et al. 2021. ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19. J Clin Epidemiol. https://doi.org/10.1016/j.jclinepi.2021.06.005.
   Google Scholar
• Pfizer initiates Phase 1 study of novel oral antiviral therapeutic agent against SARS-CoV-2. 2021. [accessed 2021 Aug 17]. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-initiates-phase-1-study-novel-oral-antiviral.
   Google Scholar
• Piccoli L, Park Y-J, Alejandra Tortorici M, Czudnochowski N, Walls AC, Beltramello M, Silacci-Fregni C, Pinto D, Rosen LE, Bowen JE, et al. 2020. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell. 183(4):1024–1042.e21. https://doi.org/10.1016/j.cell.2020.09.037.
   PubMed Web of Science ®Google Scholar
• Pierce CA, Preston-Hurlburt P, Dai Y, Aschner CB, Cheshenko N, Galen B, Garforth SJ, Herrera NG, Jangra RK, Morano NC, et al. 2020, Oct 7. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci Transl Med. 12(564):eabd5487. https://doi.org/10.1126/scitranslmed.abd5487. Epub 2020 Sep 21. PMID: 32958614; PMCID: PMC7658796.
   PubMed Web of Science ®Google Scholar
• Pietrobon AJ, Teixeira FME, Sato MN. 2020. Immunosenescence and inflammaging: risk factors of severe COVID-19 in older people. Front Immunol. 11:579220. https://doi.org/10.3389/fimmu.2020.579220.
   PubMed Web of Science ®Google Scholar
• Pinna G. 2021. Sex and COVID-19: a protective role for reproductive steroids. Trends Endocrinol Metab. 32:3–6. https://doi.org/10.1016/j.tem.2020.11.004.
   PubMed Web of Science ®Google Scholar
• Plante JA, Liu Y, Liu J, Xia H, Johnson BA, Lokugamage KG, Zhang X, Muruato AE, Zou J, Fontes-Garfias CR, et al. 2020. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. https://doi.org/10.1038/s41586-020-2895-3.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. 2020. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 383:2603–2615. https://doi.org/10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Portmann-Baracco A, Bryce-Alberti M, Accinelli RA. 2020. Propiedades antivirales y antiinflamatorias de ivermectina y su potencial uso en COVID-19. Archivos de Bronconeumología. 56:831. https://doi.org/10.1016/j.arbres.2020.06.011.
   Google Scholar
• Pottegård A, Lund LC, Karlstad Ø, Dahl J, Andersen M, Hallas J, Lidegaard Ø, Tapia C, Gulseth HL, Ruiz PLD, et al. 2021. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. Br Med J. 373:n1114. https://doi.org/10.1136/bmj.n1114.
   PubMed Web of Science ®Google Scholar
• Prado T, Fumian TM, Mannarino CF, Resende PC, Motta FC, Eppinghaus ALF, Chagas do Vale VH, Braz RMS, Andrade JSR, Maranhão AG, et al. 2021. Wastewater-based epidemiology as a useful tool to track SARS-CoV-2 and support public health policies at municipal level in Brazil. Water Res. https://doi.org/10.1016/j.watres.2021.116810.
   Google Scholar
• Prokunina-Olsson L, Alphonse N, Dickenson RE, Durbin JE, Glenn JS, Hartmann R, Kotenko SV, Lazear HM, O’Brien TR, Odendall C, et al. 2020, May 4. COVID-19 and emerging viral infections: the case for interferon lambda. J Exp Med. 217(5):e20200653. https://doi.org/10.1084/jem.20200653.
   Web of Science ®Google Scholar
• Pruijssers AJ, Denison MR. 2019. Nucleoside analogues for the treatment of coronavirus infections. Curr Opin Virol. 35:57–62. https://doi.org/10.1016/j.coviro.2019.04.002.
   PubMed Web of Science ®Google Scholar
• PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19. June 17, 2020. https://ir.ptcbio.com/node/12966/pdf.
   Google Scholar
• Rahman MT, Idid SZ. 2021. Can Zn be a critical element in COVID-19 treatment? Biol Trace Elem Res. 199:550–558. https://doi.org/10.1007/s12011-020-02194-9.
   Web of Science ®Google Scholar
• Ramaiah MJ. 2020. mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19, Gene Reports, 20. https://doi.org/10.1016/j.genrep.2020.100765.
   Google Scholar
• Rambaut A, Loman N, Pybus O, Barclay W, Barrett J, Carabelli A, Connor T, Peacock T, Robertson DL, Volz E. 2021. On behalf of COVID-19 Genomics Consortium UK (CoG-UK). Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological. [accessed 2021 Aug 17]. https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563.
   Google Scholar
• Rao M, Gershon M. 2016. The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol. 13:517–528. https://doi.org/10.1038/nrgastro.2016.107.
   PubMed Web of Science ®Google Scholar
• Rappazzo CG, Tse LV, Kaku CI, Wrapp D, Sakharkar M, Huang D, Deveau LM, Yockachonis TJ, Herbert AS, Battles MB, et al. 2021, Jan 25. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science. eabf4830. https://doi.org/10.1126/science.abf4830. Epub ahead of print. PMID: 33495307.
   Web of Science ®Google Scholar
• Rausch JW, Capoferri AA, Katusiime MG, Patro SC, Kearney MF. 2020, Oct. Low genetic diversity may be an achilles heel of SARS-CoV-2. Proc Natl Acad Sci USA. 117(40):24614–24616. https://doi.org/10.1073/pnas.2017726117.
   Web of Science ®Google Scholar
• REACT working group. 2021. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19. A meta-analysis. JAMA. https://doi.org/10.1001/jama.2021.11330.
   Google Scholar
• Reche PA. 2020. Potential cross-reactive immunity to SARS-CoV-2 from common human pathogens and vaccines. Front Immunol. 11:586984. https://doi.org/10.3389/fimmu.2020.586984.
   PubMed Web of Science ®Google Scholar
• RECOVERY Collaborative Group. 2021b. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. https://doi.org/10.1016/S0140-6736(21)00676-0.
   Google Scholar
• Rehman M, Tauseef I, Aalia B, Shah SH, Junaid M, Haleem KS. 2020. Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future. Future Virol. https://doi.org/10.2217/fvl-2020-0137.
   Google Scholar
• Reiter RJ, Abreu-Gonzalez P, Marik PE, Dominguez-Rodriguez A. 2020a. Therapeutic algorithm for use of melatonin in patients With COVID-19. Front Med (Lausanne). 7:226. https://doi.org/10.3389/fmed.2020.00226.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Sharma R, Ma Q, Dominquez-Rodriguez A, Marik PE, Abreu-Gonzalez P. 2020b. Melatonin inhibits COVID-19-induced cytokine storm by reversing aerobic glycolysis in immune cells: a mechanistic analysis. Med Drug Discovery. 6:100044. https://doi.org/10.1016/j.medidd.2020.100044.
   PubMedGoogle Scholar
• Resende PC, Bezerra JF, de Vasconcelos RHT, Arantes I, Appolinario L, Mendonça AC, Paixao AC, Rodrigues ACD, Silva T, Rocha AS, et al.. 2021. Spike E484 K mutation in the first SARS-CoV-2 reinfection case confirmed in Brazil. Virological. [accessed 2021 Aug 17]. https://virological.org/t/spike-e484k-mutation-in-the-first-sars-cov-2-reinfection-case-confirmed-in-brazil-2020/584.
   Google Scholar
• Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, Holden SJ, Raber J, Banks WA, Erickson MA. 2020. The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice. Nat Neurosci. https://doi.org/10.1038/s41593-020-00771-8.
   Google Scholar
• Robson F, Khan KS, Le TK, Paris C, Demirbag S, Barfuss P, Rocchi P, Ng W-L, et al. 2020. Coronavirus RNA proofreading: molecular basis and therapeutic targeting. Mol Cell. 79:710–727. https://doi.org/10.1016/j.molcel.2020.07.027.
   PubMed Web of Science ®Google Scholar
• Romano M, Ruggiero A, Squeglia F, Maga G, Berisio R. 2020. A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells. 9:1267. https://doi.org/10.3390/cells9051267.
   PubMed Web of Science ®Google Scholar
• Root-Bernstein R. 2020. Age and location in severity of COVID-19 pathology: Do lactoferrin and pneumococcal vaccination explain Low infant mortality and regional differences? BioEssays. 42:2000076. https://doi.org/10.1002/bies.202000076.
   PubMed Web of Science ®Google Scholar
• Roy-Vallejo E, Purificación AS, Torres JD, Sánchez Moreno B, Arnalich F, García Blanco MJ, López Miranda J, Romero-Cabrera JL, Herrero Gil CR, Bascunana J, et al. 2021. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers withdrawal is associated with higher mortality in hospitalized patients with COVID-19. J Clin Med. 10(12):2642. https://doi.org/10.3390/jcm10122642.
   Web of Science ®Google Scholar
• Rubio-Rivas M, Corbella X, Mora-Luján JM, Loureiro-Amigo J, López Sampalo A, Yera Bergua C, Esteve Atiénzar PJ, Díez García LF, Gonzalez Ferrer R, Plaza Canteli S, et al. 2020. Predicting clinical outcome with phenotypic clusters in COVID-19 pneumonia: an analysis of 12,066 hospitalized patients from the Spanish Registry SEMI-COVID-19. J Clin Med. 9:3488. https://doi.org/10.3390/jcm9113488.
   Web of Science ®Google Scholar
• Sabino EC, Buss LF, Carvalho MPS, Prete CA, Crispim MAE, Fraiji NA, Pereira RHM, Parag KV, da Silva Peixoto P, Kraemer MUG, et al. 2021. Resurgence of COVID-19 in manaus, Brazil, despite high seroprevalence. Lancet. https://doi.org/10.1016/S0140-6736(21)00183-5.
   Google Scholar
• Sacramento CQ, Fintelman-Rodrigues N, Temerozo JR, de Paula Dias Da Silva A, da Silva Gomes Dias S, dos Santos da Silva C, Ferreira Ferreira, Mattos M, Pão CRR, de Freitas CS, et al. 2020. The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2. bioRxiv. https://doi.org/10.1101/2020.06.15.153411.
   Google Scholar
• Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, Stoop J, Tete S, Van Damme W, Leroux-Roels I, et al. 2021. Interim results of a phase 1–2a trial of Ad26.COV2.S covid-19 vaccine. N Engl J Med. https://doi.org/10.1056/NEJMoa2034201.
   Web of Science ®Google Scholar
• Sadria M, Layton AT, Beard DA. 2020. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers during the COVID-19 pandemic: a modeling analysis. PLoS Comput Biol. 16:e1008235. https://doi.org/10.1371/journal.pcbi.1008235.
   Web of Science ®Google Scholar
• Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19. ClinicalTrials.gov Identifier: NCT04716998. Last Update Posted: 2021, January 22. https://clinicaltrials.gov/ct2/show/NCT04716998
   Google Scholar
• Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia (RELEASE). ClinicalTrials.gov Identifier: NCT04578210. Last Update Posted: 2020, October 19. https://clinicaltrials.gov/ct2/show/NCT04578210.
   Google Scholar
• Sagar M, Reifler K, Rossi M, Miller NS, Sinha P, White LF, Mizgerd JP. 2021. Recent endemic coronavirus infection is associated with less-severe COVID-19. J Clin Invest. 131(1):e143380. https://doi.org/10.1172/JCI143380.
   Web of Science ®Google Scholar
• Salem ML, El-Hennawy D. 2020. The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19. Med Hypotheses. 140:109752. https://doi.org/10.1016/j.mehy.2020.109752.
   PubMed Web of Science ®Google Scholar
• Salonia A, Pontillo M, Capogrosso P, Gregori S, Tassara M, Boeri L, Carenzi C, Abbate C, Cignoli D, Ferrara AM, et al. 2021, Feb 26. Severely low testosterone in males with COVID-19: a case-control study. Andrology. https://doi.org/10.1111/andr.12993.
   Google Scholar
• Sama IE, Ravera A, Santema BT, van Goor H, ter Maaten JM, Cleland JGF, Rienstra M, Friedrich AW, Samani NJ, Ng LL, et al. 2020, May 14. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors. Eur Heart J. 41(19):1810–1817. https://doi.org/10.1093/eurheartj/ehaa373.
   PubMed Web of Science ®Google Scholar
• Sánchez-Guijo F, García-Arranz M, López-Parra M, Monedero P, Mata-Martínez C, Santos A, Sagredo V, Álvarez-Avello JM, Guerrero JE, Pérez-Calvo C, et al. 2020. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study. EClinicalMedicine. 25:100454. https://doi.org/10.1016/j.eclinm.2020.100454.
   PubMedGoogle Scholar
• Sanchez-Trincado JL, Gomez-Perosanz M, Reche PA. 2017. Fundamentals and methods for T- and B-cell epitope prediction. J Immunol Res. 2017:1–14. Article ID 2680160, https://doi.org/10.1155/2017/2680160.
   Web of Science ®Google Scholar
• Sanchez-Vazquez R, Guio-Carrion A, Zapatero-Gaviria A, Martinez P, Blasco MA. 2021. Shorter telomere lengths in patients with severe COVID-19 disease. Aging (Albany NY). 13:1–15. https://doi.org/10.18632/aging.202463.
   PubMedGoogle Scholar
• Sang P, Tian S-H, Meng Z-H, Yang L-Q. 2020. Anti-HIV drug repurposing against SARS-CoV-2. RSC Adv. 27. https://doi.org/10.1039/D0RA01899F.
   Google Scholar
• Santos JC, Passos GA. 2021. The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between spike-ACE2 caused by the viral N501Y mutation. bioRxiv. https://doi.org/10.1101/2020.12.29.424708.
   Google Scholar
• SARS-CoV-2 Variant Classifications and Definitions. 2021. Center for Disease Control and Prevention, CDC. [accessed 2021 Aug 17]. https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html.
   Google Scholar
• SARS-CoV-2 variants dashboard. 2021. European Center for Disease Prevention and Control, eCDC. [accessed 2021 Aug 17]. Available at: https://www.ecdc.europa.eu/en/covid-19/situation-updates/variants-dashboard.
   Google Scholar
• Schirinzi T, Landi D, Liguori C. 2020. COVID-19: dealing with a potential risk factor for chronic neurological disorders. J Neurol. https://doi.org/10.1007/s00415-020-10131-y.
   Google Scholar
• Schmitz A, Weber A, Bayin M, Breuers S, Fieberg V, Famulok M, Mayer G. 2021. A SARS-CoV-2 spike binding DNA aptamer that inhibits pseudovirus infection by an RBD-independent mechanism. Angew Chem, Int Ed. 60:10279–10285. https://doi.org/10.1002/anie.202100316.
   Web of Science ®Google Scholar
• Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol. 1:519–525. https://doi.org/10.1016/j.coviro.2011.10.008.
   PubMed Web of Science ®Google Scholar
• Schreiber KH, O’Leary MN, Kennedy BK. 2016. Chapter 2 – The mTOR pathway and aging. In: Matt R. Kaeberlein, George M. Martin, editor. Handbook of the biology of aging. 8th ed. Academic Press; https://doi.org/10.1016/B978-0-12-411596-5.00002-2.
   Google Scholar
• Schroeder M, Schaumburg B, Müller Z, Parplys A, Jarczak D, Nierhaus A, Kloetgen A, Schneider B, Peschka M, Stoll F, et al. 2020. Sex hormone and metabolic dysregulations are associated with critical illness in male covid-19 patients. medRxiv. https://doi.org/10.1101/2020.05.07.20073817.
   Google Scholar
• Schultze A, Walker AJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, Rentsch CT, Williamson E, Drysdale H, Croker R, et al. 2020. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 8(11):1106–1120. https://doi.org/10.1016/S2213-2600(20)30415-X.
   PubMed Web of Science ®Google Scholar
• Scientific Brief: SARS-CoV-2 and Potential Airborne Transmission. Updated 2020, Oct. 5. https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.html
   Google Scholar
• Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, O’Halloran JA, Goss C, Rauseo AM, Liu Z, Sahu SK, et al. 2021. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight. https://doi.org/10.1172/jci.insight.143299.
   Google Scholar
• Sekine T, Perez-Potti A, Rivera-Ballesteros O, Strålin K, Gorin JB, Olsson A, Llewellyn-Lacey S, Kamal H, Bogdanovic G, Muschiol S, et al. 2020. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 183:158–168.e14. https://doi.org/10.1016/j.cell.2020.08.017.
   PubMed Web of Science ®Google Scholar
• Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F, et al. 2020, May. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA. 117(21):11727–11734. http://doi.org/10.1073/pnas.2003138117.
   PubMed Web of Science ®Google Scholar
• Sharma S, Thomas PG. 2014. The two faces of heterologous immunity: protection or immunopathology. J Leukocyte Biol. 95:405–416. https://doi.org/10.1189/jlb.0713386.
   PubMed Web of Science ®Google Scholar
• Shen B, Yi X, Sun Y, Bi X, Du J, Zhang C, Quan S, Zhang F, Sun R, Qian L, et al. 2020. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 182(1):59–72.e15. https://doi.org/10.1016/j.cell.2020.05.032.
   PubMed Web of Science ®Google Scholar
• Sheybani Z, Dokoohaki MH, Negahdaripour M, Dehdashti M, Zolghadr H, Moghadami M, Masoompour SM, Zolghadr AR. 2020. The role of folic acid in the management of respiratory disease caused by COVID-19. ChemRxiv. https://doi.org/10.26434/chemrxiv.12034980.v1.
   Google Scholar
• Shibata S, Arima H, Asayama K, Hoshide S, Ichihara A, Ishimitsu T, Kario K, Kishi T, Mogi M, Nishiyama A, et al. 2020. Hypertension and related diseases in the era of COVID-19: a report from the Japanese society of hypertension task force on COVID-19. Hypertens Res. 43:1028–1046. https://doi.org/10.1038/s41440-020-0515-0.
   PubMed Web of Science ®Google Scholar
• Shirvaliloo M. 2021. Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection. Epigenomics. https://doi.org/10.2217/epi-2021-0057.
   Google Scholar
• Silva J, Lucas C, Sundaram M, Israelow B, Wong P, Klein J, Tokuyama M, Lu P, Venkataraman A, Liu F, et al. 2021. Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality. medRxiv. https://doi.org/10.1101/2021.01.04.21249236.
   Google Scholar
• Sinagra E, Utzeri E, Morreale GC, Fabbri C, Pace F, Anderloni A. 2020. Microbiota-gut-brain axis and its affect inflammatory bowel disease: pathophysiological concepts and insights for clinicians. World J Clin Cases. 8(6):1013–1025. https://doi.org/10.12998/wjcc.v8.i6.1013.
   Web of Science ®Google Scholar
• Smith SJ, Busby J, Heaney LG, Pfeffer PE, Jackson DJ, Yang F, Fowler SJ, Menzies-Gow A, Idris E, Brown T, et al. 2020. The impact of the first COVID19 surge on severe asthma patients in the UK. which is worse: the virus or the lockdown? ERJ Open Res. https://doi.org/10.1183/23120541.00768-2020.
   Google Scholar
• Smith TP, Flaxman S, Gallinat AS, Kinosian SP, Stemkovski M, Unwin HJT, Watson OJ, Whittaker C, Cattarino L, Dorigatti I, et al. 2021, June. Temperature and population density influence SARS-CoV-2 transmission in the absence of nonpharmaceutical interventions. Proc Natl Acad Sci USA. 118(25):e2019284118. https://doi.org/10.1073/pnas.2019284118.
   Web of Science ®Google Scholar
• Solanich X, Vargas-Parra G, van der Made CI, Simons A, Schuurs-Hoeijmakers J, Antolí A, del Valle J, Rocamora-Blanch G, Setién F, Esteller M, et al. 2021. Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19. Front Immunol. 12:719115. https://doi.org/10.3389/fimmu.2021.719115.
   PubMed Web of Science ®Google Scholar
• Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, Lu P, Weizman OE, Liu F, Dai Y, et al. 2021, March 1. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 218(3):e20202135. https://doi.org/10.1084/jem.20202135.
   PubMed Web of Science ®Google Scholar
• Stanford University. 2021. SARS-COV-2 antiviral therapy. [accessed 2021 Aug 17]. https://covdb.stanford.edu/page/covid-review/.
   Google Scholar
• Starr TN, Greaney AJ, Addetia A, Hannon WW, Choudhary MC, Dingens AS, Li JZ, Bloom JD. 2021, Jan 25. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science. eabf9302. https://doi.org/10.1126/science.abf9302. Epub ahead of print. PMID: 33495308.
   Google Scholar
• Statkute E, Rubina A, O’Donnell VB, Thomas DW, Stanton RJ. 2020. Brief report: the virucidal efficacy of oral rinse components against SARS-CoV-2 in vitro. bioRxiv. https://doi.org/10.1101/2020.11.13.381079.
   Google Scholar
• Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, Bach K, Sungnak W, Worlock KB, Yoshida M, et al. 2021. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med. https://doi.org/10.1038/s41591-021-01329-2.
   Google Scholar
• Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claër L, Quentric P, Fadlallah J, Devilliers H, Ghillani P, et al. 2021, Jan 20. Iga dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 13(577):eabd2223. https://doi.org/10.1126/scitranslmed.abd2223. Epub 2020 Dec 7. PMID: 33288662.
   PubMed Web of Science ®Google Scholar
• Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, et al. 2020. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 26:681–687. https://doi.org/10.1038/s41591-020-0868-6.
   PubMed Web of Science ®Google Scholar
• Taboada M, Caruezo V, Naveira A, Atanassoff PG. 2020. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease. J Clin Anesth. 66:109926. https://doi.org/10.1016/j.jclinane.2020.109926.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, Silva J, Mao T, Oh JE, Tokuyama M, et al. 2020. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 588:315–320. https://doi.org/10.1038/s41586-020-2700-3.
   PubMed Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang Y-Q, Wang Q, Miao H. 2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduction Targeted Ther. 5:33. https://doi.org/10.1038/s41392-020-0148-4.
   PubMed Web of Science ®Google Scholar
• Tang D, Comish P, Kang R, Hobman TC. 2020a. The hallmarks of COVID-19 disease. PLOS Pathogens. 16(5):e1008536. http://dx.doi.org/10.1371/journal.ppat.1008536.
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, Sun Z. 2020b. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemostasis. 18:844–847. https://doi.org/10.1111/jth.14768.
   PubMed Web of Science ®Google Scholar
• Tardif J-C, Bouabdallaoui N, L'Allier PL, Gaudet D, Shah B, Pillinger MH, Lopez-Sendon J, da Luz P, Verret L, Audet S, et al. 2021. Efficacy of colchicine in Non-hospitalized patients with COVID-19. medRxiv. https://doi.org/10.1101/2021.01.26.21250494.
   Google Scholar
• Tarke A, Sidney J, Kidd CK, Dan JM, Ramirez SI, Yu ED, Mateus J, da Silva Antunes R, Moore E, Rubiro P, et al. 2021a. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Reports Med. 2(2):100204. https://doi.org/10.1016/j.xcrm.2021.100204.
   PubMedGoogle Scholar
• Tarke A, Sidney J, Methot N, Yu ED, Zhang Y, Dan JM, Goodwin B, Rubiro P, Sutherland A, Wang E, et al. 2021b. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals. Cell Reports Med. https://doi.org/10.1016/j.xcrm.2021.100355.
   Google Scholar
• Taylor BL, Waghray A, Mbano IM, Miao VN, Tzouanas CN, Cao Y, Yousif AS, Bals J, Hauser BM, Feldman J, et al. 2020. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and Is detected in specific cell subsets across tissues. Cell. 181. https://doi.org/10.1016/j.cell.2020.04.035.
   Google Scholar
• Taylor EH, Marson EJ, Elhadi M, Macleod KDM, Yu YC, Davids R, Boden R, Overmeyer RC, Ramakrishnan R, Thomson DA, et al. 2021. Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis. Anaesthesia. https://doi.org/10.1111/anae.15532.
   Google Scholar
• Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N, et al. 2020. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv. https://doi.org/10.1101/2020.12.21.20248640.
   Google Scholar
• Testar J. 2021. Cytokines: Introduction. UK: Imperial College London. [accessed 2021 Aug 17]. https://www.immunology.org/public-information/bitesized-immunology/receptors-and-molecules/cytokines-introduction.
   Google Scholar
• The COVID-19 Sex-Disaggregated Data Tracker. 2021. [accessed 2021 Aug 17]. https://globalhealth5050.org/the-sex-gender-and-covid-19-project/.
   Google Scholar
• The human protein atlas. 2021. ACE2. [accessed 2021 Aug 17]. https://www.proteinatlas.org/ENSG00000130234-ACE2/tissue.
   Google Scholar
• Thépaut M, Luczkowiak J, Vivès C, Labiod N, Bally I, Lasala F, Grimoire Y, Fenel D, Sattin S, Thielens N, et al. 2021. DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist. PLoS Pathog. 17(5):e1009576. https://doi.org/10.1371/journal.ppat.1009576.
   PubMed Web of Science ®Google Scholar
• The Severe Covid-19 GWAS Group. 2020. Genomewide association study of severe covid-19 with respiratory failure. N Engl J Med. 383:1522–1534. https://doi.org/10.1056/NEJMoa2020283.
   Web of Science ®Google Scholar
• Thomas RL, Jiang L, Adams JS, Xu ZZ, Shen J, Janssen S, Ackermann G, Vanderschueren D, Pauwels S, Knight R, et al. 2020. Vitamin D metabolites and the gut microbiome in older men. Nat Commun. 11:5997. https://doi.org/10.1038/s41467-020-19793-8.
   PubMed Web of Science ®Google Scholar
• Thomson EC, Rosen LE, Shepherd JG, Spreafico R, da Silva Filipe A, Wojcechowskyj JA, Davis C, Piccoli L, Pascall DJ, Dillen J, et al. 2021. Circulating SARS-CoV-2 spike N439 K variants maintain fitness while evading antibody-mediated immunity. Cell. https://doi.org/10.1016/j.cell.2021.01.037.
   Google Scholar
• Tizabi Y, Getachew B, Copeland RL, Aschner M. 2020. Nicotine and the nicotinic cholinergic system in COVID-19. FEBS J. 287:3656–3663. https://doi.org/10.1111/febs.15521.
   PubMed Web of Science ®Google Scholar
• Tomaszewski T, DeVries RS, Dong M, Bhatia G, Norsworthy MD, Zheng X, Caetano-Anollés G. 2020, Oct 23. New pathways of mutational change in SARS-CoV-2 proteomes involve regions of intrinsic disorder Important for virus replication and release. Evol Bioinform Online. 16:1176934320965149. https://doi.org/10.1177/1176934320965149. PMID: 33149541; PMCID: PMC7586267.
   Web of Science ®Google Scholar
• Torres Acosta MA, Singer BD. 2020, Sep 24. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population. Eur Respir J. 56(3):2002049. https://doi.org/10.1183/13993003.02049-2020. PMID: 32747391; PMCID: PMC7397945.
   Web of Science ®Google Scholar
• Tortora G, Funke B, Case C. 2019. Microbiology: An introduction, 13th. Pearson. ISBN: 9780134709260.
   Google Scholar
• Tosif S, Neeland MR, Sutton P, Licciardi PV, Sarkar S, Selva KJ, Do LAH, Donato C, Quan Toh Z, Higgins R, et al. 2020. Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19. Nat Commun. 11:5703. https://doi.org/10.1038/s41467-020-19545-8.
   PubMed Web of Science ®Google Scholar
• Turner JS, Kim W, Kalaidina E, Goss CW, Rauseo AM, Schmitz AJ, Hansen L, Haile A, Klebert MK, Pusic I, et al. 2021a. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. https://doi.org/10.1038/s41586-021-03647-4.
   Google Scholar
• Turner JS, O’Halloran JA, Kalaidina E, Kim W, Schmitz AJ, Zhou JQ, Lei T, Thapa M, Chen RE, Case JB, et al. 2021b. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. https://doi.org/10.1038/s41586-021-03738-2.
   Google Scholar
• Uludağ H, Parent K, Aliabadi HM, Haddadi A. 2020. Prospects for RNAi therapy of COVID-19. Front Bioeng Biotechnol. 8:916. https://doi.org/10.3389/fbioe.2020.00916.
   Web of Science ®Google Scholar
• van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, van Deuren RC, Steehouwer M, van Reijmersdal SV, Jaeger M, et al. 2020. Presence of genetic variants among young Men With severe COVID-19. JAMA. 324(7):663–673. https://doi.org/10.1001/jama.2020.13719.
   PubMed Web of Science ®Google Scholar
• Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. 2020. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 395:1417–1418. https://doi.org/10.1016/S0140-6736(20)30937-5.
   PubMed Web of Science ®Google Scholar
• Volz E, Hill V, McCrone JT, Price A, Jorgensen D, O’Toole A, Southgate J, Johnson R, Jackson B, Nascimento FF, et al. 2021. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 184(1):64–75.e11. https://doi.org/10.1016/j.cell.2020.11.020.
   PubMed Web of Science ®Google Scholar
• Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L, Hinsley WR, Laydon DJ, Dabrera G, O’Toole A, et al. 2020. The COVID-19 genomics UK (COG-UK) consortium, Seth Flaxman, Oliver Ratmann, Samir Bhatt, Susan Hopkins, Axel Gandy, Andrew Rambaut, Neil M Ferguson. medRxiv. https://doi.org/10.1101/2020.12.30.20249034.
   Google Scholar
• Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. 2021. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet J. 397:0. https://doi.org/10.1016/S0140-6736(20)32661-1.
   Web of Science ®Google Scholar
• Wahl A, Gralinski LE, Johnson CE, Yao W, Kovarova M, Dinnon KH, Liu H, Madden VJ, Krzystek HM, De C, et al. 2021. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature. https://doi.org/10.1038/s41586-021-03312-w.
   Google Scholar
• Wajnberg A, Amanat F, Firpo A, Altman DR, Bailey MJ, Mansour M, McMahon M, Meade P, Mendu DR, Muellers K, et al. 2020. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 370(6521):1227–1230. https://doi.org/10.1126/science.abd7728.
   PubMed Web of Science ®Google Scholar
• Wang C, Li W, Drabek D, Okba NMA, van Haperen R, Osterhaus ADME, van Kuppeveld FJM, Haagmans BL, Grosveld F, Bosch BJ. 2020. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun. 11:2251. https://doi.org/10.1038/s41467-020-16256-y.
   PubMed Web of Science ®Google Scholar
• Wang P, Nair MS, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, et al. 2021a. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 593(7857):130–135. http://dx.doi.org/10.1038/s41586-021-03398-2.
   PubMed Web of Science ®Google Scholar
• Wang S, Qiu Z, Hou Y, Deng X, Xu W, Zheng T, Wu P, Xie S, Bian W, Zhang C, et al. 2021b. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Research. 31(2):126–140. http://dx.doi.org/10.1038/s41422-020-00460-y.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang C, Song Y, Coleman JR, Stawowczyk M, Tafrova J, Tasker S, Boltz D, Baker R, Garcia L, et al. 2021c. Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy. Proc Nat Acad Sci (PNAS). 118(29):e2102775118. https://doi.org/10.1073/pnas.2102775118.
   PubMed Web of Science ®Google Scholar
• Ward SE, Fogarty H, Karampini E, Lavin M, Lavin M, Schneppenheim S, Dittmer R, Morrin H, Glavey S, Ni Cheallaigh C, et al. 2021. ADAMTS13 regulation of VWF multimer distribution in severe COVID-19. J Thromb Haemostasis. https://doi.org/10.1111/jth.15409.
   Google Scholar
• Wark PA, Pathinayake PS, Kaiko G, Nichol K, Ali A, Chen L, Sutanto EN, Garratt LW, Sohal SS, Lu W, et al. 2020. ACE2 expression is elevated in Airway Epithelial Cells from aged and male donors but reduced in asthma. medRxiv. https://doi.org/10.1101/2020.07.26.20162248.
   Google Scholar
• Wei J, Alfajaro MM, DeWeirdt PC, Hanna RE, Lu-Culligan WJ, Cai WL, Strine MS, Zhang SM, Graziano VR, Schmitz CO, et al. 2021. Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection. Cell. 184(1):76–91.e13. https://doi.org/10.1016/j.cell.2020.10.028.
   PubMed Web of Science ®Google Scholar
• Weisberg SP, Connors TJ, Zhu Y, Baldwin MR, Lin WH, Wontakal S, Szabo PA, Wells SB, Dogra P, Gray J, et al. 2021. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol. 22:25–31. https://doi.org/10.1038/s41590-020-00826-9.
   PubMed Web of Science ®Google Scholar
• Wesley Long S, Olsen RJ, Christensen PA, Bernard DW, Davis JJ, Shukla M, Nguyen M, Saavedra MO, Yerramilli P, Pruitt L, et al. 2020, Oct. Molecular architecture of early dissemination and massive second wave of the SARS-CoV-2 virus in a major metropolitan area. mBio. 11(6):e02707–20. https://doi.org/10.1128/mBio.02707-20.
   Web of Science ®Google Scholar
• Wessels I, Rolles B, Rink L. 2020. The potential impact of zinc supplementation on COVID-19 pathogenesis. Front Immunol. 11:1712. https://doi.org/10.3389/fimmu.2020.01712.
   PubMed Web of Science ®Google Scholar
• Westendorf K, Žentelis S, Foster D, Vaillancourt P, Wiggin M, Lovett E, van der Lee R, Hendle J, Pustilnik A, Sauder JM, et al. 2021. LY-CoV1404 potently neutralizes SARS-CoV-2 variants. bioRxiv. https://doi.org/10.1101/2021.04.30.442182.
   Google Scholar
• White KM, Rosales R, Yildiz S, Kehrer T, Miorin L, Moreno E, Jangra S, Uccellini MB, Rathnasinghe R, Coughlan L, et al. 2021. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science. https://doi.org/10.1126/Science.Abf4058.
   Google Scholar
• Woodruff MC, Ramonell RP, Eun-Hyung Lee F, Sanz I. 2020a. Clinically identifiable autoreactivity is common in severe SARS-CoV-2 infection. medRxiv. https://doi.org/10.1101/2020.10.21.20216192.
   Google Scholar
• Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, Ley AM, Kyu S, Howell JC, Ozturk T, et al. 2020b. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol. 21:1506–1516. https://doi.org/10.1038/s41590-020-00814-z.
   PubMed Web of Science ®Google Scholar
• Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, et al. 2020a. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica. B 10. https://doi.org/10.1016/j.apsb.2020.02.008.
   Google Scholar
• Wu KJ, Zimmer C, Corum J. Coronavirus Drug and Treatment Tracker. Updated 2021, Feb 2. https://www.nytimes.com/interactive/2020/science/coronavirus-drugs-treatments.html.
   Google Scholar
• Wu Y, Wang F, Shen C, Peng W, Li D, Zhao C, Li Z, Li S, Bi Y, Yang Y, et al. 2020b. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 368(6496):1274–1278. http://dx.doi.org/10.1126/science.abc2241.
   PubMed Web of Science ®Google Scholar
• Wyllie D, Mulchandani R, Jones HE, Trickey A, Taylor-Phillips S, Brooks T, Charlett A, Ades AE, Moore P, Boyes J, et al. 2021. SARS-CoV-2 responsive T cell numbers are associated with protection. from COVID-19: a prospective cohort study in keyworkers. medRxiv. https://doi.org/10.1101/2020.11.02.20222778.
   Google Scholar
• Xie X, Zou J, Fontes-Garfias CR, et al. 2021. Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera. bioRxiv. https://doi.org/10.1101/2021.01.07.425740.
   Google Scholar
• Xu Y, Jiang H. 2020. Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase. Protein Cell. 11:699–702. https://doi.org/10.1007/s13238-020-00769-9.
   Web of Science ®Google Scholar
• Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, Fehlmann T, Stein JA, Schaum N, Lee DP, et al. 2021. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. https://doi.org/10.1038/s41586-021-03710-0.
   Google Scholar
• Yao Y, Wang H, Liu Z. 2020. Expression of ACE2 in airways: implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases. Clin Exp Allergy. 50:1313–1324. https://doi.org/10.1111/cea.13746.
   PubMed Web of Science ®Google Scholar
• Young BE, Fong S-W, Chan Y-H, Mak T-M, Ang LW, Anderson DE, Lee CY-P, Amrun SN, Lee B, Goh YS, et al. 2020. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet. 396(10251):603–611. https://doi.org/10.1016/S0140-6736(20)31757-8.
   PubMed Web of Science ®Google Scholar
• Yuan S, Yin X, Meng X, Chan JF-W, Ye Z-W, Riva L, Pache L, Chan CC-Y, Lai P-M, Chan CC-S, et al. 2021. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2. Nature. https://doi.org/10.1038/s41586-021-03431-4.
   Google Scholar
• Yue J, Qin L, Zhang C, Xie M. 2020. Reply. J Allergy Clin Immunol. 146. https://doi.org/10.1016/j.jaci.2020.06.002.
   Google Scholar
• Zanettini C, Omar M, Dinalankara W, Imada EL, Colantuoni E, Parmigiani G, Marchionni L. 2021. Influenza vaccination and COVID-19 mortality in the USA: an ecological study. Vaccines (Basel). 9(5):427. https://doi.org/10.3390/vaccines9050427.
   Web of Science ®Google Scholar
• Zeberg H, Pääbo S. 2020. The major genetic risk factor for severe COVID-19 is inherited from neanderthals. Nature. 587:610–612. https://doi.org/10.1038/s41586-020-2818-3.
   PubMed Web of Science ®Google Scholar
• Zhang J, Saad R, Taylor EW, Rayman MP. 2020a. Selenium and selenoproteins in viral infection with potential relevance to COVID-19. Redox Biol. 37:101715. https://doi.org/10.1016/j.redox.2020.101715.
   PubMed Web of Science ®Google Scholar
• Zhang J-M, An J. 2007. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 45(2):27–37. https://doi.org/10.1097/AIA.0b013e318034194e.
   PubMedGoogle Scholar
• Zhang L, Richards A, Barrasa MI, Hughes SH, Young RA, Jaenisch R. 2021a. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proceedings of the National Academy of Sciences. 118(21):e2105968118. http://dx.doi.org/10.1073/pnas.2105968118.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, Ogishi M, Sabli IKD, Hodeib S, Korol C, et al. 2020b. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 370. http://doi.org/10.1126/science.abd4570.
   Google Scholar
• Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, Liu C, Reiter RJ. 2020c. COVID-19: melatonin as a potential adjuvant treatment. Life Sci. 250:117583. https://doi.org/10.1016/j.lfs.2020.117583.
   PubMed Web of Science ®Google Scholar
• Zhang SD, Lu J. 2020. In silico design of siRNAs targeting existing and future respiratory viruses with virus. bioRxiv. https://doi.org/10.1101/2020.08.13.250076.
   Google Scholar
• Zhang Y, Guo R, Kim SH, Shah H, Zhang S, Liang JH, Fang Y, Gentili M, Leary CNO’, Leary SJ, et al. 2021b. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication. Nat Commun. 12:1676. https://doi.org/10.1038/s41467-021-21903-z.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Chen Y, Luo B, Yuan Y, Huang F, Yang T, Yu F, Liu J, Liu B, et al. 2020d. The ORF8 protein of SARS-CoV-2 mediates immune evasion through potently downregulating MHC-I. bioRxiv. https://doi.org/10.1101/2020.05.24.111823.
   Google Scholar
• Zheng D, Liwinski T, Elinav E. 2020a. Interaction between microbiota and immunity in health and disease. Cell Res. 30:492–506. https://doi.org/10.1038/s41422-020-0332-7.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Li R, Liu S. 2020b. Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: a novel intervention strategy beyond vaccines and specific antiviral medicines. J Med Virol. 92:1495–1500. https://doi.org/10.1002/jmv.26009.
   PubMed Web of Science ®Google Scholar
• Zhou D, Duyvesteyn HME, Chen CP, Huang C-G, Chen T-H, Shih S-R, Lin Y-C, Cheng C-Y, Cheng S-H, Huang Y-C, et al. 2020a. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat Struct Mol Biol. 27:950–958. https://doi.org/10.1038/s41594-020-0480-y.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. 2020b. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 395. https://doi.org/10.1016/S0140-6736(20)30566-3.
   Google Scholar
• Zimmermann P, Curtis N. 2020. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. https://doi.org/10.1136/archdischild-2020-320338.
   Web of Science ®Google Scholar
• Zoufaly A, Poglitsch M, Aberle JH, Hoepler W, Seitz T, Traugott M, Grieb A, Pawelka E, Laferl H, Wenisch C, et al. 2020. Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir Med. 8:1154–1158. https://doi.org/10.1016/S2213-2600(20)30418-5.
   PubMed Web of Science ®Google Scholar
• Zumla A, Chan J, Azhar E, Hui DSC, Yuen K-Y. 2016. Coronaviruses — drug discovery and therapeutic options. Nat Rev Drug Discovery. 15:327–347. https://doi.org/10.1038/nrd.2015.37.
   PubMed Web of Science ®Google Scholar
• Zuo T, Liu Q, Zhang F, Lui GC-Y, Tso EYK, Yeoh YK, Chen Z, Boon SS, Chan FKL, Chan PKS, et al. 2021. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 70:276–284. https://doi.org/10.1136/gutjnl-2020-322294.
   PubMed Web of Science ®Google Scholar
• Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, Chen N, Li A, Lu W, Chan FKL, et al. 2020a. Alterations in fecal fungal microbiome of patients With COVID-19 during time of hospitalization until discharge. Gastroenterology. 159(4). https://doi.org/10.1053/j.gastro.2020.06.048.
   Google Scholar
• Zuo Y, Estes SK, Ali RA, et al. 2020b. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 12(570):eabd3876. https://doi.org/10.1126/scitranslmed.abd3876.
   PubMed Web of Science ®Google Scholar